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Demonstration of a transition-
metal promoted reaction in a
living tissue modelMartı́nez et al. demonstrate the feasibility of using core-shell Pd/MOF
nanoreactors as intracellular metallo-catalysts, which can be reused within the
same cells with recurrent batches of reactants, both in adherent cell cultures and in
spheroids. The MOF-based shell preserves the integrity of the catalytic chamber
while providing for bio-orthogonality.Martı́nez et al., Cell Reports Physical Science 1,
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Translating the potential of transition metal catalysis to biological
and living environments promises to have a profound impact in
chemical biology and biomedicine. A major challenge in the field is
the creation of metal-based catalysts that remain active over time.
Here, we demonstrate that embedding a reactive metallic core
within a microporous metal-organic framework-based cloak pre-
serves the catalytic site from passivation and deactivation, while al-
lowing a suitable diffusion of the reactants. Specifically, we report
the fabrication of nanoreactors composed of a palladium nanocube
core and a nanometric imidazolate framework, which behave as
robust, long-lasting nanoreactors capable of removing propargylic
groups from phenol-derived pro-fluorophores in biological milieu
and inside living cells. These heterogeneous catalysts can be reused
within the same cells, promoting the chemical transformation of
recurrent batches of reactants. We also report the assembly of tis-
sue-like 3D spheroids containing the nanoreactors and demonstrate
that they can perform the reactions in a repeated manner.
INTRODUCTION
Intracellular enzymes play an essential role in maintaining and controlling the cell’s
metabolism and function and have evolved to catalyze life-sustaining reactions.
Scientists are not limited by the constraints of life and evolution and can therefore
aspire to develop non-natural catalytic reactors capable of working inside living
environments. These systems could provide unprecedented opportunities for
cellular intervention and eventually lead to the discovery of innovative biomedical
tools.1
Within the catalysis field, transition metal catalysis is especially appealing, owing to
the innumerable type of transformations that can be achieved. Although most of
these reactions have been carried out in organic solvents and under water-free
conditions, recent years have witnessed a significant increase in metal-mediated re-
actions that can occur in complex aqueous environments and even within living
mammalian cells.2–8 Initial work in the field was focused on homogeneous copper-
promoted azide-alkyne annulations9–14 and ruthenium-mediated uncaging reac-
tions;15–20 however, more recently, other metals, like gold,19,21,22 iridium,23
osmium,24 and palladium,25 have also demonstrated potential to induce specific
transformations of exogenous substrates in biological settings. Unfortunately, these
catalysts tend to be deactivated over time and therefore cannot be used in a recur-
rent, long-lasting manner.Cell Reports Physical Science 1, 100076, June 24, 2020 ª 2020 The Author(s).
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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degraded or deactivated when used in complex biological media.26–29 As an alter-
native, there have been several attempts to use Pd nanoparticles as heterogeneous
catalysts.27,30 However, in absence of a suitable surface functionalization,31,32 the
nanoparticles tend to aggregate and suffer from Pd leaching, and their surface is
easily passivated by biological components of the milieu.27,33 On the other hand,
the functionalization of nanoparticles with organic coatings, typically required to
fabricate colloidally stable systems, can dramatically decrease their catalytic
capability.34
Bradley and Unciti-Broceta have nicely approached some of these issues by embed-
ding ‘‘pristine’’ Pd nanoparticles within polystyrene microspheres.35,36 This hetero-
geneous formulation allowed to carry out designed uncaging reactions in biological
media and even in the presence of mammalian cells; however, as the own authors
noted, the solvent-exposed nanoparticles can become deactivated over time
because of fouling.37
In an effort to avoid the passivation of the Pd surface, we engineered hollow silica
microcapsules containing Pd nanoparticles in the internal cavity and demonstrated
that they can be used for uncaging reactions in phosphate-buffered saline (PBS) and
in the presence of added proteins. However, despite these promising results, themi-
crocapsules were not effective in intracellular settings.38
Overall, achieving efficient bio-orthogonal Pd-catalyzed reactions in complex
aqueous media, and especially inside living cells, stands as a challenge in research
at the interface between catalysis and cell biology. More importantly, the develop-
ment of robust, intracellular metallic reactors that remain active over time, and can
thus process recurrent batches of reactants, is yet to be accomplished.
Metal-organic frameworks (MOFs), porous materials self-assembled frommetal ions
and organic ligands, have attracted attention for gas storage and biomedical appli-
cations, such as drug delivery, imaging, and biosensing.39 In recent years, they have
also demonstrated great potential in metal-promoted heterogeneous catalysis.40,41
In this context, a number of palladium-containing MOF structures have been used as
catalysts to promote hydrogenations,42 oxidations,43 and even C-C bond-forming
processes.44 Not surprisingly, most of these MOF-promoted reactions have been
carried out in organic solvents and under water-free conditions, due to the well-
known sensitivity of most MOF architectures to the presence of bulk water.45–50
Although several MOF-based composites compatible with aqueous media have
been made, for instance, for removal of pollutants from waste water,51 their use
for transition metal catalysis in aqueous milieu remains essentially unexplored.52,53
Needless to say, they have never been used in living settings, except for a pioneer-
ing report involving MOF-supported copper nanocomposites for achieving azide-
alkyne cycloadditions in presence of cells.54 The distribution of copper nanoparticles
in the MOF nanocomposite (including solvent-exposed catalytic centers), however,
does not allow to discern whether the reaction occurs in the surface and/or
throughout the nanocomposite.
Herein, we report water-compatible core-shell Pd/ZIF-8 nanocomposites capable of
working as efficient, and long-lasting bio-orthogonal heterogeneous nanoreactors.
The nanocomposite features a single Pd nanocube core (the catalyst) and a porous









Figure 1. Core-Shell Pd/ZIF-8 Nanoreactor (NR) for Intracellular Reactions
(A) Pd nanocubes (Pd-NPs) coated by a porous ZIF-8/PMA shell are colloidally and structurally stable in water.
(B) The NRs tend to accumulate in cytosolic compartments (endosomes/lysosomes) and work as heterogeneous palladium-based nanoreactors capable
of processing substrates, even in a recurrent manner.
(C) Reacting probes (substrates 1, 3, and 5) used in our study; below, their corresponding fluorescent products (2, 4, and 6) resulting from a Pd-promoted
removal of their propargylic protecting groups (see Figures S1–S9 and Supplemental Experimental Procedures).
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renders the nanocomposite stable in aqueous media.55 Importantly, we demon-
strate that the ZIF-8/PMA architecture not only protects the Pd nanocatalyst from
deactivation, leaking, and aggregation, but its porosity allows a diffusion-controlled
flow of reactants within the core reaction chamber (Figure 1A). As a result, these con-
structs can be used as efficient metallo-nanoreactors (NRs) in complex aqueous
media and inside living mammalian cells. The nanoplatforms tend to be stored in
cytosolic vesicles, remaining stable, active, and accessible to the reactants (see
Supplemental Experimental Procedures and Figures S1–S9), and can therefore pro-
mote consecutive reaction runs using new batches of reactants, without losing
efficiency (Figures 1B and 1C). Importantly, we also demonstrate that these NRs
can be readily incorporated into 3D tumor spheroids to produce tissue-like catalytic
systems, which can also work in a recurrent, dose-dependent manner. This type of
‘‘catalytic tissues,’’ which might lead to ‘‘in vivo’’ catalytic engineering, is also
unprecedented.
RESULTS AND DISCUSSION
Design and Synthesis of the Pd/ZIF-8 Nanocomposites
Pd nanocubes (Pd-NPs from now) were selected as catalytic cores, owing to their
shape-enhanced catalytic performance.56 The selected nanocubes with side length
24 nm (Figure S10) were synthesized in aqueous solution at room temperature
(23C), in the presence of the cationic surfactant hexadecyltrimethylammonium
bromide (CTAB), using K2PdCl4 as Pd source and L-ascorbic acid as reducing





Figure 2. Characterization of the Core-Shell Pd/ZIF-8 Nanoreactors
(A) Transmission electron microscopy (TEM) micrographs confirm the core-shell Pd/ZIF-8 structure
(without PMA).
(B) Scanning electron microscopy (SEM) micrographs of the same core-shell Pd/ZIF-8 particle using
different detectors, at different voltages, provide depth-dependent structural and textural
information. Top-left: Everhart-Thornley detector (type II, SE2, secondary electrons) at 3 kV is
shown. Top-right: InLens detector (type I, SE1, secondary electrons) at 20 kV is shown. Down: AsB
detector (backscattered electrons) at 3 kV (left) and 20 kV (right) is shown.
(C) SEM micrographs of PMA-derivatized Pd/ZIF-8 nanocomposites (NRs) using two detectors at 20
kV (left: InLens detector, secondary electrons; right: AsB detector, backscattered electrons).
(D) Mean dh of NRs and Pd-NPs in different media: water, 10% FBS supplemented cell medium,
artificial lysosomal fluid (ALF), and 10% FBS supplemented ALF. * indicates immediate, irreversible
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250 nm (Figures 2A, 2B, and S11). This synthetic approach allows fabricating one
Pd/ZIF-8 particle per Pd-NP seed, as shown by electron microscopy. Pd/ZIF-8 parti-
cles exhibit the characteristic Bragg peaks of ZIF-8 and Pd0, as shown by powder
X-ray diffraction (PXRD) (Figure S12; Table S1). Importantly, the resulting nanosys-
tems were post-functionalized with the amphiphilic polymer PMA, in order to intro-
duce aqueous stability.
Albeit related core-shell metal NP/ZIF-8 composites have been previously reported
using other surfactants,58 or different nanoparticle cores,59 the inherent aqueous
instability of ZIF-8 is well known; indeed, this ZIF-8 characteristic has been used
for the progressive release of encapsulated drugs inside cells.48,60–62 Notice that,
when such composites are internalized into cells, they tend to accumulate in lyso-
somes, where the acidic pH accelerates the ZIF-8 degradation and hence the release
of the drug. Such aqueous instability is, however, incompatible with the potential
use of these nanostructures as biocompatible heterogeneous catalysts.
Our PMA-modified Pd/ZIF-8 nanocomposites (in the following referred to as NRs;
Figure 2C) with z-potential 30 mV are colloidally stable in aqueous solution, as
well as in supplemented (10% fetal bovine serum [FBS]) cell medium and in artificial
lysosomal fluid (ALF) (plain or supplemented with 10% FBS). Dynamic light scattering
(DLS) demonstrates that they remain stable for at least 1 week (hydrodynamic diam-
eter [dh]250 nm; see Figures 2D and S13; Table S2). In contrast to our NRs, Pd-NPs
(equivalent to the Pd cores of NRs) rapidly aggregate and precipitate in water or ALF
buffer, albeit they remain colloidally stable in supplemented cell medium or supple-
mented ALF (Figure 2D), likely due to the adsorption of serum proteins.
Inductively coupled plasma mass spectrometry (ICP-MS) was used to corroborate
the Pd content before and after the ZIF-8 coating (Table S3), as well as to quantify
the amount of Pd per Pd/ZIF-8 particle (3.8 wt %). Taking geometrical and structural
considerations regarding the Pd-NPs used herein,56,63 we estimate that 5% of the
Pd content of one Pd-NP are surface atoms (surface Pd) and thereby potentially avail-
able for the catalytic processes (Table S4). Importantly, although the specific surface
area of the NRs decreases after PMA-modification,55 likely because the PMA
partially fills voids in the nanostructure, the ZIF-8 shell remains porous and accessible
for small molecule loading by diffusion, as demonstrated with model fluorescent
probes (Table S5; Figure S14).NR-Catalyzed Removal of Propargylic Groups in Aqueous Solution
With the water-compatible Pd/MOF structures (NRs) at hand, we tested their cata-
lytic performance in the depropargylation of the coumarin derivative 1 (Figure 1C).
This is a reaction that we had already studied with discrete Pd complexes29 and with
hollow nanocapsules38 and therefore represents an excellent reference to assess
and compare the transformative potential of our system.
Gratifyingly, when the propargyl-protected coumarin 1 (10 mM) was mixed with the
NRs in water/methanol (9:1) at 37C for 15 h, we observed a smooth formation of the
fluorescent coumarin 2 (89% using 50 mol % of surface Pd and 97% using 100 mol %;aggregation and precipitation. Note: using water with 10% MeOH, instead of only water, the
colloidal stability of the NRs is similar. The error bars represent 2s value for each datapoint (s, SD of
the diameter mean value as obtained from three repetitions of the measurement).
Scale bars are 200 nm.
Cell Reports Physical Science 1, 100076, June 24, 2020 5
A B C
Figure 3. Characterization of the Pd-Promoted (NR or Pd-NP) Depropargylation of Pro-coumarin 1 in Aqueous Solution
(A) Yield (%) of 2 using increasing concentrations of the NRs and, therefore, of surface Pd (10%, 50%, 100%, and 150% mol surface Pd); reaction
conditions: 10 mM of 1, H2O:MeOH 9:1, 37
C, 15 h.
(B) Reusability comparison between NRs and Pd-NPs; reaction conditions: 100% mol surface Pd, 10 mM of 1, H2O:MeOH 9:1, 37
C, 15 h.
(C) Pd leaking after one run.
The error bars represent 2s value for each datapoint (s, SD, calculated from three independent measurements).
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action is slower but also effective (37% or 99% yield after 15 h or 7 days, respectively;
Table S7), confirming that the nanocomposite behaves as a true catalyst. Notice that
we quantified the amount of generated product in the supernatant of the reaction
mixture after precipitation of our NRs; therefore, we also considered the washing
steps required to fully recover the generated product (Table S8).
The NR-promoted deprotection of 1 can also be carried out in PBS/MeOH (9:1)
instead of water/methanol (9:1), leading to similar results. A control experiment us-
ing similar ZIF-8 particles lacking the Pd core confirmed the need of the Pd core to
promote the depropargylation reaction (Table S6).
Remarkably, pristine Pd-NPs, under identical conditions, led to much more modest
yields, which could be in part explained in terms of their poor colloidal stability (Fig-
ures 3B and S15). Indeed, although the Pd content of the NRs remained virtually un-
altered, in the case of the Pd-NPs, their integrity was significantly disrupted after just
one cycle (>16% Pd leaking; Figure 3C; Table S9). Importantly, the NRs can be re-
cycled without compromising their catalytic activity, as corresponds to a true hetero-
geneous nanocatalyst. Indeed, as shown in Figure 3B, after four runs of overnight re-
action with 1, the NRs were just as effective as in the first round. In contrast, Pd-NPs
gradually lost efficacy after each use, which is in consonance with their poor colloidal
stability under the reaction conditions (Figure 3B; Table S10).
We also explored the uncaging of the propargyl derivative of 2-(20-hydroxyphenyl)
benzothiazole (3; Figure 1C), a probe that emits light at longer wavelengths. Surpris-
ingly, in this case, the reaction did not proceed; however, it can be achieved with
pristine Pd-NPs (15% yield after 15 h; Table S6). Although this result could be consid-
ered unsatisfactory, it is rather valuable from amechanistic perspective. DLS data re-
sulting from exposing the NRs to 1 and/or 3 suggest that the lack of reaction in the
case of substrate 3 is likely due to the coordination of the thiazole nitrogen atom to

















Figure 4. Characterization of the Pd-Promoted (NR or Pd-NP) Generation of Fluorophores 2 or 6 in Biological Media
(A) Yield of coumarin 2 in the presence of increasing concentrations of BSA (10 mM of 1, 37C, 15 h).
(B) Yield of 2 in the presence of media of increasing biocomplexity (10 mM of 1, 37C, 15 h unless otherwise noted).
(C) NR’s performance as catalyst for the depropargylation of 5 in the presence of media of increasing biocomplexity (10 mM of 5, 37C, 15 h). In all the
cases, the concentration of NR or Pd-NP was kept constant at 0.23 nM, z100 mol % surface Pd.
The error bars represent 2s value for each datapoint.
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adding one equivalent of the benzothiazole 3 to the reaction of pro-coumarin 1
with the NRs compromises the reaction rate, albeit still allowing the formation of
product 2 in 54% yield (after 15 h) and in quantitative yield after 72 h (Table S6; Fig-
ure S16). These observations confirm the filtering role of the ZIF-8 shell; that is, only
substrates that can permeate through the porous structure will be able to reach the
nanoreactor’s core. Therefore, the MOF structure not only protects the reactive Pd
core but also allows discrimination among reactants, which might be especially rele-
vant in terms of orthogonality.
As expected, the NRs can efficiently promote the depropargylation of other precur-
sors that do not feature zinc coordinating moieties, even in substrates containing
two propargyl caging groups. This is the case of the bis-protected cresyl violet 5
(Figure 1C). We observed a similar reaction trend than with the pro-coumarin 1 in
terms of yield, reusability, and turnover number (TON) (Table S7). Additionally, we
confirmed that the reaction exclusively affords the fully deprotected cresyl violet
6, with no traces of monopropargylated intermediates (Figure S17). In this case,
we also tested consecutive reaction runs using the same NRs (10 mM surface Pd)
and adding the substrate 5 (10 mM) up to three times separated by18 h. The cumu-
lative yield of the product 6 (>250%; Table S12) demonstrates the feasibility of the
NRs to work as true heterogeneous flow nanoreactors.
Bio-orthogonality
The shell-based architecture of the microporous ZIF-8 structure allows not only to
protect the Pd core from colloidal degradation and/or Pd leaking but also filters
large components of biological mixtures, thereby partially preventing Pd inactiva-
tion by biomolecule adsorption. As shown in Figure 4A, the reaction of the propar-
gylated coumarin 1 tolerates the presence of excess amounts of bovine serumCell Reports Physical Science 1, 100076, June 24, 2020 7
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ecules of BSA per NR particle), four times more than typically contained in supple-
mented cell media, the reaction yield was over 30% (after 15 h). Using pristine Pd-
NPs instead of our NRs, the yields are low (<10%).
The NRs are also effective in media of higher complexity, such as Dulbeccós modi-
fied Eagle’s medium (DMEM) supplemented with 10% FBS, or HeLa cell lysates,
albeit the reaction yields after 15 h were modest (Figure 4B). However, leaving the
reaction in DMEM (10% FBS) for a longer time (72 h), the yield increases up to
47%, which confirms the ability of the NR to remain active for long periods, even
in a crowded molecular environment. Analogous bio-orthogonality experiments us-
ing the cresyl violet precursor 5 led to similar results (Figure 4C; Table S13).
Intracellular Reactions
Having demonstrated and quantified the catalytic performance of our Pd/MOF par-
ticles in aqueous media with increasing biocomplexity, our next aim consisted of
demonstrating that such chemistry can be performed inside living mammalian cells.
Toward this end, we first carried out viability studies using HeLa cells supplemented
with different concentrations of either the NRs, Pd-NPs, and/or the bispropargyl
carbamate-protected cresyl violet 5 (Figure S18). This allowed us to set the range
of concentrations for substrates and reagents compatible with >90% cell viability
(24 h incubation, %2 mM in surface Pd, equivalent to%50 pM NRs;%45 mM bispro-
pargyl carbamate-protected cresyl violet 5). The pristine Pd-NPs did not impair
viability in the concentration range studied here (0.3–167 mM in surface Pd content,
equivalent to 7 pM–4 nM Pd-NPs). Control experiments with cresyl violet (6; ex-
pected product of the intracellular depropargylation) revealed a higher toxicity
than the protected precursor (using 0.6 mM; 25% viability after 24 h incubation;
Figure S18).
Cell uptake experiments with fluorescently labeled NRs (50 pM) confirmed an effi-
cient internalization and the accumulation in the endocytic compartments (endo-
somes or lysosomes) after 12 h (Figure S19). ICP-MS was used to quantify the
average Pd content (Table S14), which thereby allowed us to estimate the average
number of NRs per cell (120). We also quantified the amount of internalized Pd
when using Pd-NPs instead of the NRs, resulting in a decreased intracellular Pd con-
tent (71 Pd-NPs) per cell, which is not surprising, owing to the poorer colloidal sta-
bility of the pristine Pd-NPs.
The Pd-promoted reactions were performed by first incubating the cells with the NRs
(50 pM, equivalent to 2 mM in surface Pd, overnight) to obtain NR-preloaded cells.
Before adding the substrate 5, cells were extensively washed with PBS to ensure that
non-internalized or membrane-bound particles were removed.
Due to the toxicity profile of the cresyl violet 6, we used confocal microscopy to test
different substrate concentrations and incubation times (Figures S20–S24); as a con-
trol, cresyl violet was also added to cells without NRs to confirm its intracellular dis-
tribution by confocal microscopy (Figure S25). We were glad to observe that, after
incubating NR-preloaded cells for 6 h with 2.5 or 10 mM of 5, there is a clear dose-
dependent buildup in cellular fluorescence associated to the production of 6 (Fig-
ure 5A). Not surprising, when using higher concentrations of 5, we started to observe
certain toxicity, as we generate more product. Indeed, there is a similar impair
(50%) in cell viability after 24 h, when cells are exposed to 0.15 mM of cresyl violet
6 (the product), or by addition of 10 mM of the bisprotected precursor 5 to8 Cell Reports Physical Science 1, 100076, June 24, 2020
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Figure 5. NR-Promoted Intracellular Depropargylation Reactions
(A) Confocal microscopy images (603) after incubation of NR-preloaded cells with different concentration of substrate 5 (top: 2.5 mM; down: 10 mM;
603; the fluorescence corresponds to the intracellular production of cresyl violet 6).
(B) Confocal images (1003) after incubation of 5 (10 mM) with NR-preloaded cells at different incubation times (1–24 h).
(C) Comparison of the intracellular fluorescence generated in the reactions of substrate 5 (corrected total cell fluorescence [CTCF] per cell) achieved by
our NR or other palladium reagents (Pd-NPs; Pd-1: [Pd(allyl)Cl]2; Pd-2: [(PPh3)Pd(allyl)Cl]; or Pd-3: [PdCl2(TFP)2]), using equivalent incubation conditions
(2 mM of Pd overnight) and cell treatment (PBS washings and incubation with of 10 mM of substrate 5 during 6 h); at least 35 cells per catalyst were
analyzed (see Figure S26).
In (A), images on the right panel correspond to merged images (bright-field plus fluorescence channels). The error bars represent 2s value for each
datapoint (s, SD, calculated from at least 35 cells per catalyst). In all cases, cells pretreated with the palladium reagents were washed with PBS (three
times) before adding fresh medium and the substrates. Scale bars correspond to 20 mm (1003) or 40 mm (603).
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cytotoxic product.
Interestingly, when the reaction of 5 (10 mM) was analyzed at different incubation
times (1, 3, 6, and 24 h), we observed a fluorescence maximum intensity around 3
h, whereas, after 24 h, there is a significant decrease in emission (Figure 5B). This
result suggests that the product 6 is slowly expelled out of the cells.
We should acknowledge at this point that Pd-NPs (50 pM, equivalent to 2 mM in
surface Pd, overnight), which lack the MOF shell, also promoted the intracellular
generation of cresyl violet (6). However, as expected from the test tube experiments,
the efficiency was considerably lower than with the NRs (Figure S26). This is also re-
flected from the less impaired viability (that is, less cresyl violet production from 5) in
cells pretreated with Pd-NPs than with our NRs (Figure S18).Cell Reports Physical Science 1, 100076, June 24, 2020 9
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carried out equivalent cellular reactivity studies using three state-of-the-art Pd




30 In consonance with previous reports on related depropargylation
reactions, these homogeneous catalysts showed only marginal activity in the intra-
cellular uncaging of 5 (2 mM Pd; overnight incubation; Figure S26). A comparative
analysis using a fluorescence readout (corrected total cell fluorescence [CTCF] per
cell) confirmed that our NRs outperform these catalysts, leading to CTCF per cell
15 times higher than those obtained with Pd-2, which was the best among these
complexes (Figures 5C and S26). The reasons for this improved performance of
our metallo-nanoreactors inside living cells must be related to the core-shell nano-
architecture in which the MOF-based shell plays a critical role to protect the metal
reactive chamber from deactivation while providing for a controlled flow of
reactants.
Diffusion-Controlled Core-Shell Pd/ZIF-8 as Recurrent Intracellular
Nanoreactors
The above studies confirm that the designed Pd/MOF nanocomposites are readily
internalized into mammalian cells and are capable of promoting intracellular depro-
pargylation reactions. We then envisioned that the core-shell, microporous structure
of our constructs could allow an efficient flow of reagents and products without dam-
age to the core catalytic Pd, and therefore, the Pd/ZIF-8 platforms might work as
recyclable nanoreactors. Accordingly, we examined the feasibility of reusing the
nanocatalyst-loaded cells, which can be especially relevant in terms of accomplish-
ing the long-term goal of developing ‘‘catalytic cellular implants.’’
Given that product 6 seems to be readily washed out of the cells, we explored the
viability of using our Pd/MOF platforms as recurrent (flow) intracellular nanoreactors
(Figure 6A). Therefore, the NR-preloaded cells were incubated during 3 h with the
substrate 5 (20 mM = run-1) as previously discussed, and the intracellular formation
of cresyl violet 6 after 3 h was confirmed by confocal microscopy (Figure 6B, left).
Cells were then washed twice with PBS to remove extracellular substrates/products
and mixed with fresh cell medium to facilitate the cleansing of product 6 and of re-
maining reactants. Indeed, after 3 h of cleansing, there is almost no intracellular fluo-
rescence (Figure 6B, right), whereas cell viability does not appear significantly
affected; that is, similar cell densities were observed. Notice that, although in the ex-
periments shown in Figure 5B, there are not washing steps before confocal inspec-
tion, in the experiments of Figure 6 (cleansing panels), cells were washed after 3 h of
incubation. This allows removing products and creates a concentration gradient that
further promotes the extracellular release and the cleansing process. Next, cells
were incubated with a second dose of substrate 5 (20 mM = run-2) during 3 h. We
observed again a rise up of fluorescence associated to the production of 6 (Fig-
ure 6C, right), which was cleared by the cells after the cleansing treatment (run-2/
cleansing; Figure 6C, left). We repeated this protocol up to 4 cycles (Figure 6; addi-
tional images in Figure S27) with similar outcomes, which demonstrates the robust-
ness of our heterogeneous nanoreactors to perform dose-dependent, sustained
intracellular transformations. For completeness, we also attempted equivalent ex-
periments with either the pristine Pd-NPs or the homogeneous catalysts (Pd-1, Pd-
2, and Pd-3). Not surprisingly, these reagents, which already performed poorly in
a first cycle, were unable to sustain a second reaction cycle (Figure S26). These re-
sults further corroborate the unique performance of our NRs in this type of recurrent
reactivity and represent a first approach to the development of reusable ‘‘catalytic




Figure 6. NR-Preloaded Cells Working as Recurrent ‘‘Flow’’ Nanoreactors
(A) Reusability scheme (4 cycles) demonstrated for the deprotection of precursor 5.
(B–D) First, second, and third reaction runs using the same NR-preloaded cells and recorded by confocal microscopy; left: after 3 h incubation with 5;
right: after washing (2xPBS) and leaving the cells for 3 h for further cleansing (see main text).
(E) Two images of the fourth deprotection run of precursor 5 with the same NR-preloaded cells.
In (B)–(E), confocal images (1003) correspond to merged channels: bright-field plus fluorescence. Scale bars correspond to 20 mm (1003).
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Having demonstrated the potential of our NRs to carry out intracellular depropargy-
lation reactions in adherent 2D cultured cells and the viability of using these NR-con-
taining cells in a recurrent manner, we questioned whether the reactivity could be ex-
ported to tissue-like models. This would be an important step to further narrowing
the frontier between transition metal catalysis and cellular biology and biomedicine.
In particular, we wondered whether it would be possible to build 3D tissue-like sys-
tems containing our NRs and whether these cellular networks could be capable of
performing the designed metal-promoted reactions. We chose 3D tumor spheroids
asmodels of avascular tissues (Figure S28), as they are widely used in cancer research
as intermediatemodels between in vitro cancer cell line cultures and in vivo tumors.64
To test the viability of building these spheroids, we first used NRs in which the PMA
contains a rhodamine tag, in order to facilitate the analysis by confocal microscopy.
Therefore, HeLa cells were loaded with these NRs as previously discussed and grown
in agarose templates for 24 h (Figure S29). Microscope inspection of the cell cultures
confirmed the presence of the desired 3D structures (developed from an initial den-
sity of13 104–33 104 cells per spheroid, which presented a diameter0.4–1 mm).Cell Reports Physical Science 1, 100076, June 24, 2020 11
Figure 7. NR-Preloaded 3D Spheroids Working as Recurrent Flow Tissue-like Reactor
(A) Top: 3D reconstruction of confocal microscopy z-scans of a NR-preloaded spheroid; NRs were fluorescently labeled (i.e., PMA was covalently
modified with a rhodamine tag). Bottom: three individual scans at different depths are shown, illustrating the homogeneous distribution of the NRs
throughout the spheroid volume.
(B) Top: 3D reconstruction of confocal microscopy z-scans of a NR-preloaded spheroid 24 h after incubation with substrate 5 (20 mM), showing the
fluorescence resulting from the generation of 6. Bottom: three individual scans at different depths are shown, illustrating the non-homogeneous ‘‘crust-
like’’ distribution of 6 throughout the spheroid volume.
(C) Top: 3D reconstruction of confocal microscopy z-scans of a NR-preloaded spheroid, which, after one reaction run with 5, was washed with PBS (three
times) and incubated for 24 h in fresh cell media, which led to cleansing of the spheroid. Bottom: three individual scans at different depths are shown to
illustrate the cleansing process at different depths.
(D) Top: 3D reconstruction of confocal microscopy z-scans of a NR-preloaded spheroid, which, after one reaction run with 5 (24 h) and the cleansing step
(24 h), was gain incubated with more substrate (5; 20 mM). Bottom: three individual scans at different depths are shown, illustrating the non-
homogeneous ‘‘crust-like’’ distribution of fluorescence (from 6) throughout the spheroid volume.
3D reconstructions were done with 300 stack images (total thickness 150 mm; step thickness 0.5 mm). Scale bars correspond to 100 mm (203).
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the spheroids (Figure 7A).
Following the same procedure, we synthesized homologous spheroids using NRs
without the fluorescent label, and their reactive potential was analyzed in the12 Cell Reports Physical Science 1, 100076, June 24, 2020
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OPEN ACCESSArticledepropargylation of bis-propargylated probe 5 (Figure S30). Excitingly, when the
NR-loaded spheroids were incubated with 5 (20 mM) for 24 h, we observed a clear
buildup of fluorescence corresponding to product 6 (Figure 7B). Curiously, and in
contrast to the homogeneous distribution of the rhodamine-labeledNRs (Figure 7A),
the fluorescence arising from 6 is non-homogeneous but mostly concentrating as a
thick ‘‘crust’’ in the spheroid. This result is not surprising, and it is very likely due to
the diffusion-limited distribution of the substrate 5, which prefers to enter the cells
located in the more external layer of the tissue model, so that the fluorescent prod-
uct is generated in these regions. It is important to note that tumor spheroids are in
fact suitable models to reproduce the heterogeneity of environments within solid tu-
mors: decreasing chemical gradients of nutrients from the outermost cells to the
hypoxic core of the spheroid.
After one run, as previously discussed for the 2D cell experiments, NR-loaded spher-
oids were washed with PBS (three times) to remove extracellular substrates/products
and fresh cell media was added, which facilitated the cleansing of 6 (for 24 h; Fig-
ure 7C). The resulting NR-loaded spheroids were again incubated with 5 (20 mM) dur-
ing 24 h. Gratifyingly, we observed a new rise up of fluorescence associated to the
production of 6 (Figure 7D), which is again mainly concentrated in the crust.
These results represent the first demonstration of a transition-metal promoted reac-
tion carried out in a living tissue model. Excitingly, these spheroids can be consid-
ered as recyclable ‘‘catalytic tissues,’’ a concept without precedent, which might
have profound implications in the future development of ‘‘catalytic cellular or tissue
implants.’’
We have demonstrated the feasibility of using Pd/ZIF-8 nanocomposites as intracel-
lular heterogeneous metallo-catalysts. In contrast to other MOF-metal hybrids,
which present active metals in the surface, our core-shell Pd/ZIF-8 architecture en-
sures that the reaction occurs in a core reaction chamber, which is critical for the bio-
logical application. The ZIF-8-based shell plays a critical role to preserve the integrity
of the catalytic chamber while providing for orthogonality (substrate selectivity) and
biocompatibility. Excitingly, our heterogeneous nanoplatforms can process sequen-
tial batches of reactants when loaded in cells, both in the form of 2D monolayers or
as 3D tumor spheroids. This represents a pioneering demonstration of intracellular
recurrent nanoreactors and may set the basis for the development of ‘‘catalytic
cellular or tissular nanoimplants.’’ To provide a comprehensive picture of the cata-
lytic behavior of our NRs inside living cells and tissues, further work will be necessary
to analytically determine the amount of intracellularly generated product, thereby
making it possible to calculate and optimize TONs.
The versatility of the nanobuilding technology promises a straightforward access to
other related nanocomposites (for instance, by integrating other metal[s] clusters or
NPs and/or metal-organic-framework-based shells), which could operate as multi-
functional nanoreactors in biological settings, and promotes many other abiotic re-
actions in living environments.EXPERIMENTAL PROCEDURES
Resource Availability
Lead Contact
Further information and requests for resources and reagents should be directed to
and will be fulfilled by the lead contact, Pablo del Pino (pablo.delpino@usc.es).Cell Reports Physical Science 1, 100076, June 24, 2020 13
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OPEN ACCESS ArticleMaterials Availability
All unique/stable reagents generated in this study are available from the lead con-
tact with a completed Materials Transfer Agreement.
Data and Code Availability
The main data supporting the findings of this study are included in the paper and its
Supplemental Information file. Additional raw data (NMR spectra, mass spectra, and
so on) are available from the lead contact on reasonable request.Synthesis of Probes
The compounds propargyl-protected coumarin 1, propargyl-protected 2-(20-hy-
droxyphenyl) benzothiazole 3, and bis-propargyl carbamate-protected cresyl violet
5 were synthesized following known procedures (see the Supplemental Experi-
mental Procedures).28,65–67Preparation of PMA-Modified Pd/ZIF-8 Nanocomposites (NRs)
The here-designed and studied NRs consisted of a Pd-NP core and a ZIF-8 shell,
which was further functionalized with a polymer (PMA). The synthetic method
involved three main steps: (1) CTAB-coated Pd nanocubes enclosed by {100} facets
were first synthesized using K2PdCl4 as precursor, L-ascorbic acid as reducing agent,
and hexadecyltrimethylammonium bromide (CTAB) as capping agent and stabilizer.
(2) These Pd-NPs were then used as seeds onto which a shell of ZIF-8 was grown by
following an aqueous procedure in which the surfactant CTAB works as size-control-
ling and structural-directing agent. (3) Finally, in order to provide colloidal stability in
diverse complex aqueous media, these Pd/ZIF-8 core-shell particles were wrapped
with the amphiphilic polymer PMA by following a recently described protocol;55
alternatively, PMA was covalently modified with a rhodamine (specifically, we used
5(6)-TAMRA cadaverine) for fluorescence labeling of our NRs, as previously reported
for analogous plasmonic nanocomposites.55Characterization Techniques
Scanning electron microscopy (SEM) and transmission electron microscopy (TEM)
were used to study the size and morphology of the nanomaterials. SEM images
were acquired with a FESEM Zeiss Ultra Plus operated at 3 kV and 20 kV. TEM images
were acquired with a JEOL JEM-2010 microscope operated between 80 and 200 kV
accelerating voltage. ImageJ free software and Origin software were used for the
size measurements and distribution analysis, respectively. Mass spectra were ac-
quired using IT-MS Bruker AmaZon SL and using electrospray ionization (ESI). UV-
Vis absorption spectra and fluorescence spectra were acquired using Jasco V-670
spectrometer and Varian Cary Eclipse fluorescence spectrofluorometer, respec-
tively. An X-ray diffractometer Philips was used to study the crystallinity of the sam-
ples, operating in the range of 2q between 2 and 75 with a passage of 0.02 and a
time by step of 2 s. A Malvern Zetasizer (Nano ZSP) instrument, equipped with a 10
mW He-Ne laser operating at a wavelength of 633 nm and fixed scattering angle of
173, was used tomeasure the hydrodynamic diameters (by DLS) and the zeta poten-
tials (by laser Doppler anemometry [LDA]). Inductively coupled plasma mass spec-
trometry (ICP-MS) measurements were performed using an Agilent 7700x ICP-MS
after acidic digestion of the samples with aqua regia. Reverse-phase high-perfor-
mance liquid chromatography-diode array detector/mass spectrometry (RP-HPLC-
DAD/MS) analysis was done by using Thermo Dionex Ultimate 3000 coupled with
a MSD Bruker AmaZon SL.14 Cell Reports Physical Science 1, 100076, June 24, 2020
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The reaction with the NRs or with Pd-NPs in aqueous solution was performed as fol-
lows: 1, 3, or 5 (8 mL; 0.5 mM stock solution in MeOH) was added to a H2O:MeOH 9:1
solution (342 mL of the reaction medium; H2O:MeOH 8:2 solution for substrate 5) in a
1.5 mL HPLC vial (containing a stirring bar), followed by addition of an aqueous so-
lution of Pd-NPs or NRs (50 mL, 2 nM, unless otherwise specified; this corresponds to
10 mM of surface Pd). Reactions were carried out overnight under continuous stirring
(400 rpm) at 37C. Afterward, the particles were collected by centrifugation (7,000
RCF; 10 min) and washed with 400 mL of reaction medium, and the generated prod-
uct (supernatant) was quantified by fluorescence.
Parameters such as the catalyst concentration, the influence of washing steps, and
the presence of bio-additives in the reaction medium were studied and evaluated.
Potential leaking of Pd during the reaction was determined by ICP-MS of the super-
natants. Procedures for obtaining kinetic curves and TONs and testing the reus-
ability of the particles (Pd-NPs or NRs) are described in the Supplemental Informa-
tion. Each experiment was performed at least in duplicate, and the values given
correspond to the mean value G standard deviation (SD) of n R 2. Each measure-
ment was taken from distinct samples. R2 is the coefficient of determination, used
as statistical parameter of goodness of fit in the calibration curves. Data analysis
was performed using OriginPro 8 statistical software.Cell Studies
We confirm that the biological material involved in the study (cervical cancer cell
line—HeLa) are readily available from standard commercial source (ATCC). A stan-
dard experiment consists of incubation of HeLa cells with the NRs or Pd-NPs (50
pM, equivalent to 2 mM in surface Pd) overnight (12 h). In all the cell studies,
before adding the substrate (5) or resazurin (for cell viability studies; Figure S18),
non-internalized nanostructures were washed out from the cell culture. In the intra-
cellular depropargylation of 5, before confocal inspections, washing of extracellular
probes (substrates and/or products) was not required.
Spheroids of HeLa cells and NR-loaded HeLa cells were produced by adapting
the application note provided by Ibidi (i.e., generation of spheroids), that is,
the manufacturer of the wells that we used for spheroid culture and confocal mi-
croscopy. As in the 2D cell studies, cells were incubated with the NRs (50 pM,
equivalent to 2 mM in surface Pd) overnight (12 h). Then, before generating
the spheroids, non-internalized NRs were washed out from the cell culture. In
the case of the intra-spheroid depropargylation of 5, before confocal inspections,
extracellular probes (substrates and/or products) were removed by washing with
PBS three times.
Cells were imaged with an Andor Dragonfly spinning disk confocal system mounted
on a Nikon TiE microscope equipped with a Zyla 4.2 PLUS camera (Andor, Oxford
Instruments) and an OKO-lab incubator to keep cells at 37C during all the experi-
ments. Images were taken with different magnification objectives (603 and 1003).
Excitation/emission wavelengths used for confocal imaging of the rhodamine-
labeled NRs/product 6 are 561/620 (60).SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.xcrp.
2020.100076.Cell Reports Physical Science 1, 100076, June 24, 2020 15
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González, A., and Mascareñas, J.L. (2019).
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Supplemental Experimental Procedures 
Synthesis and characterization of the probes and palladium complexes 
General procedures: The compounds propargyl-protected coumarin 1,1 propargyl-protected 2-(2’-
hydroxyphenyl)benzothiazole 3,2 and bis-propargyl carbamate-protected cresyl violet 5,3 are known compounds 
and were synthesized according to those previously reported procedures. Compounds 2, 4 and 6 are 
commercially available and were purchased from Sigma-Aldrich. 
Palladium complexes (Pd-1 = [Pd(allyl)Cl]2;4 Pd-2 = [(PPh3)Pd(allyl)Cl];5 Pd-3 = [(PdCl2(TFP)2]6) have been previously 
described and were synthesized from the corresponding ligands and palladium precursors following reported 
procedures. Their 1H, 13C and 31P NMR data were in complete agreement with the reported values. Precursors 
[Pd(allyl)Cl]2 and [PdCl2(CH3CN)2] are commercially available and were purchased from Sigma-Aldrich and Strem 
Chemicals, respectively. Ligands triphenylphosphine and tris(2-furyl)phosphine (TFP) were acquired from Sigma-
Aldrich.  
Reactions were conducted in dry solvents under nitrogen atmosphere using vacuum-line and standard Schlenk 
techniques unless otherwise stated. Dry solvents were freshly distilled under argon from an appropriate drying 
agent before use. The removal of solvents under reduced pressure was carried out on a rotary evaporator. Water 
was deionized and purified on a Millipore Milli-Q Integral system. The abbreviation “r.t.” refers to reactions 
carried out approximately at 23 °C (room temperature). Reaction mixtures were stirred using Teflon-coated 
magnetic stirring bars. Reaction temperatures were maintained using Thermo watch-controlled silicone oil baths. 
Thin-layer chromatography (TLC) was performed on silica gel plates (Merck 60 silica gel F254) and components 
were visualized by observation under UV light, and/or by treating the plates with p-anisaldehyde followed by 
heating. Flash chromatography was carried out in silica gel (Merck Geduran Si 60, 40 – 63 m silica gel, normal 
phase) unless otherwise stated. Dryings were performed with anhydrous Na2SO4 or MgSO4. Concentration refers 
to the removal of volatile solvents via distillation using a Büchi rotary evaporator followed by residual solvent 
removal under high vacuum.  
Mass spectra were acquired using IT-MS Bruker AmaZon SL at CiQUS and also using electrospray ionization (ESI) 
and were recorded at the CACTUS facility of the University of Santiago de Compostela. UV and fluorescence 
spectra were acquired using Jasco V-670 spectrometer and Varian Cary Eclipse fluorescence spectrofluorometer.  
 









4-Methylumbelliferone (2, 0.300 g, 1.702 mmol, 1 eq.) was dissolved in acetone (15 mL) followed by addition of 
Na2CO3 (0.361 g, 3.411 mmol, 2 eq.). The reaction mixture was stirred at r.t. for 10 min. Further, 3-bromopropyne 
(0.380 g, 2.552 mmol, 1.5 eq.) was added to the reaction and the resulting mixture was heated at reflux under 
nitrogen for 24 h. Upon completion, the reaction mixture was cooled to r.t., adsorbed onto silica and purified by 
silica gel column chromatography EtOAc (20% → 50% v/v)-hexane to give the corresponding product as a white 
solid. (1, 0.182 g, 50%). 
 
Synthesis of 3-(benzo[d]thiazol-2-yl)-5-methyl-2-(prop-2-yn-1-yloxy)benzaldehyde (3) 
 
4 (0.250 g, 0.928 mmol, 1 eq.) was dissolved in DMF (5 mL) followed by addition of K2CO3 (0.256 g, 1.864 mmol, 
2 eq.). The reaction mixture was stirred at r.t. for 10 min. Further, 3-bromopropyne (0.207 g, 1.392 mmol, 1.5 eq.) 
was added to the reaction mixture, and heated at 50 ºC under nitrogen and stirring for 24 h. Upon completion, 
the reaction mixture was cooled to r.t., concentrated under vacuum, the crude dissolved in CH2Cl2 (15 mL), 
adsorbed onto silica, and purified by silica gel column chromatography EtOAc (10% → 30% v/v)-hexane to give 
the corresponding product as a white solid. (3, 0.120 g, 42%). 
 
Synthesis of prop-2-yn-1-yl (Z)-(9-(((prop-2-yn-1-yloxy)carbonyl)amino)-5H-benzo[a]phenoxazin-5-
ylidene)carbamate (5) 
 
Procedure adapted from Bradley et al.3 1H and 13C NMR data of 5 are in agreement with the reported values.3 
Cresyl violet acetate (0.150 g, 0.467 mmol, 1 eq.) was dissolved in anhydrous DMF (5 mL) and cooled to 0 ºC 
followed by addition of Et3N (0.142 g, 1.403 mmol, 3 eq.). Propargyl chloroformate (5 eq, 2.33 mmol, 0.237 mL 
in anhydrous DMF (1 mL) was added dropwise to the solution. The reaction mixture was stirred at r.t. for 24 h and 
followed by RP-HPLC-MS. After that, it was concentrated under vacuum, dissolved in MeOH (15 mL), adsorbed 
onto silica, and purified by silica gel column chromatography EtOAc (5% → 40% v/v)-hexane to give the 
corresponding product as a red solid (5, 0.044 g, 22%). 
 
Synthesis of [(PPh3)Pd(allyl)Cl] (Pd-2) 
 
 
Procedure adapted from Mascareñas et al.5  
1H, 13C and 31P NMR data of Pd-2 are in agreement with the reported values.5 
Triphenylphosphine (0.035 mg, 0.133 mmol, 2 eq.) was dissolved in THF (3.3 mL) followed by addition of 
[Pd(allyl)Cl]2 (Pd-1, 0.024 mg, 0.066 mmol, 1 eq.). The solution was stirred at r.t. under nitrogen for 3 h. After that, 
it was concentrated under vacuum. The crude was dissolved in AcOEt (ca. 4 mL). Hexane was added (ca. 15 mL) 
and a pale yellow solid precipitated. After removal of the solvent by decantation, the solid was washed with 
hexane (3 x 10 mL) and dried under vacuum. The palladium complex (Pd-2) was isolated as a pale yellow solid 
and stored under nitrogen (0.019 g, 65%). 
 
Synthesis of [(PdCl2(TFP)2] (Pd-3) 
 
 
Procedure adapted from Weissleder et al.6 
1H, 13C and 31P NMR data of Pd-3 are in agreement with the reported values.6 
[PdCl2(CH3CN)2] (0.025 mg, 0.098 mmol, 1 eq.) was dissolved in dry MeCN (3.75 mL) followed by addition of a 
solution of tris(2-furyl)phosphine (TFP) (0.045 mg, 0.196 mmol, 2 eq.) in MeCN (0.5 mL). The reaction mixture was 
stirred at r.t. overnight and a bright yellow precipitated. The crude product was collected and washed twice with 
water (2 x 10 mL), dissolved in dried methanol and stored at -30 ºC. The palladium complex (Pd-3) was isolated 
as a yellow microcrystalline powder and stored under nitrogen (0.031 mg, 50%).  
UV and Fluorescence spectra: 
4-methyl-7-(prop-2-yn-1-yloxy)-2H-chromen-2-one (1) 
 
Figure S1. UV spectra (left) of 1 (30 µM, 1:1 v/v mixture of DMSO:Tris buffer 200 mM, pH = 7.5) and fluorescence 
spectra (10 µM, 7:3 v/v mixture of DMSO:H2O) λex 323 nm, λem 380 nm, λcut 330 nm (right). 
7-hydroxy-4-methyl-2H-chromen-2-one (2) 
 
Figure S2. UV spectra (left) of 2 (30 µM, 1:1 v/v mixture of DMSO:Tris buffer 200 mM, pH = 7.5) and 
fluorescence spectra (10 µM, 7:3 v/v mixture of DMSO:H2O) λex 323 nm, λem 452 nm, λcut 330 nm (right). 
 
Figure S3. Calibration curve of 2 (9:1 v/v H2O:MeOH), λex 323 nm, λem 452 nm. Dashed red line: linear regression 
fitting I (counts) = 1+188·c(µM); coefficient of determination R2 = 0.999.  















Figure S4. UV spectra (left) of 3 (20 µM, 7:3 v/v DMSO:H2O) and fluorescence spectra (5 µM, 7:3 v/v 




Figure S5. UV spectra (left) of 4 (20 µM, DMSO:H2O 7:3), and fluorescence spectra (5 µM, 7:3 v/v mixture of 
DMSO:H2O) at different wavelengths (λex 368 nm, λem 558 nm, λcut 380 nm and λex 460 nm, λem 535 nm, λcut 465 
nm (right). 
 
Figure S6. Calibration curve of 4 (7:3 v/v DMSO:H2O), λex 460 nm, λem 535 nm, λcut 470 nm. Dashed red line: 
linear regression fitting I (counts) = 81 + 108·c(µM); coefficient of determination R2 = 0.990.  












Figure S7. UV spectra (left) of 5 (10 µM, 8:2 PBS:MeOH), and fluorescence spectra (1 µM, 8:2 PBS:MeOH) under 




Figure S8. UV spectra (left) of 6 (10 µM, 8:2 PBS:MeOH), and fluorescence spectra (1 µM, 8:2 PBS:MeOH) under 
excitation at λex=540 nm; maximum emission at λem=624 nm (right). 
 
 
Figure S9. Calibration curve of 6 (8:2 PBS:MeOH), λex=540 nm, λem=624 nm. Dashed red line: linear regression 
fitting I·105 (counts) = 0.006 + 8.504·c(µM); coefficient of determination R2 = 0.998.  
Synthesis of PMA-modified Pd/ZIF-8 nanocomposites (NRs) 
Chemicals: All the reagents including potassium tetrachloropalladium (II) (K2PdCl4; Sigma Aldrich #205796), L-
ascorbic acid (AA; Sigma Aldrich #A5960), zinc nitrate hexahydrate (Zn(NO3)2·6H2O; Sigma Aldrich #96482), 2-
methylimidazole (MeIm; Sigma Aldrich #M50850), and hexadecyltrimethylammonium bromide (CTAB; Sigma 
Aldrich #H5882) were used as purchased without any purification. The PMA-based amphiphilic polymer (i.e., 
poly[isobutylene–alt–maleic anhydride]–graft–dodecyl) was synthesized as described previously.7  
Synthesis of Pd nanocubes: CTAB-coated Pd nanocubes enclosed by {100} facets were synthesized according to 
a previously reported protocol,8 using K2PdCl4 as precursor, L-ascorbic acid (AA) as reducing agent, and 
hexadecyltrimethylammonium bromide as capping agent and stabilizer. In a typical synthesis, 0.5 mL of 0.1 M 
CTAB, 21.25 mL of deionized water and 2.5 mL of 0.01 M K2PdCl4 were placed in a 50 mL glass vial, and then 
0.75 mL of 0.1 M AA was added while magnetic stirring. The mixture is stirred at room temperature for some 
minutes (~5 min) observing during this time that the solution turns into black color, which indicates the formation 
of the Pd nanocubes (in the following referred to as Pd-NPs). Next, the black product was collected by 
centrifugation (7200 RCF, 10 min), washed twice with MilliQ water to remove the excess of CTAB (Figure S10), 
and finally the purified Pd-NPs were redispersed in 1.4×10-3 M CTAB. 
Synthesis of Pd/ZIF-8: These particles were synthesized according to a previously reported protocol with slight 
modifications.9 The Pd-NPs were used as seeds onto which a shell of ZIF-8 was grown, in the presence of CTAB 
as size-controlling and structural-directing agent, obtaining in this way the core-shell nanocomposite. Briefly, an 
aqueous solution of zinc nitrate (1 mL, 0.025 M) was added to an aqueous solution of 2-methylimidazole (1 mL, 
1.3 M) under magnetic stirring (350 rpm) at r.t., and immediately after, a solution containing the Pd-NPs (1mL, 2 
nM of nanoparticles dispersed in 1.4×10-3 M of CTAB) was added. After 2 min, the stirring was stopped, and the 
mixture was left undisturbed for 3 h at r.t. The gradual appearance of brownish turbidity indicated the formation 
of the Pd/ZIF-8 particles. Finally, the particles were collected by centrifugation (7000 RCF, 5 min), washed twice 
with methanol (MeOH) and redispersed in 1 mL of MeOH. The concentration of particles in this solution was 
assumed to be ~2 nM, considering that one Pd/ZIF-8 particle was formed per Pd-NP (seed). Note that under 
optimized conditions virtually all the ZIF-8 particles contained a Pd-NP as core (Figure S11). 
Post-functionalization of Pd/ZIF-8 with PMA polymer: The as-prepared Pd/ZIF-8 particles were functionalized with 
a PMA-based amphiphilic polymer (i.e., poly[isobutylene–alt–maleic anhydride]–graft–dodecyl) by following a 
recently described protocol.9 Briefly, the Pd/ZIF-8 particles dispersed in methanol were mixed with the solution 
of the polymer in chloroform in an optimized proportion; specifically, 150 monomers of polymer per nm2 of 
Pd/ZIF-8 particle, assuming a spherical particle with diameter of 250 nm; and the mixture was placed in a rotary 
evaporator. After complete evaporation of the solvent (3:1 MeOH:CHCl3) the dried product was resuspended by 
addition of sodium borate buffer (0.1 M, pH 9) and aided by sonication (1-2 min). The resulting PMA-modified 
Pd/ZIF-8 nanocomposites (in the following referred to as NRs) were collected and purified by centrifugation (7000 
RCF, 10 min), washing twice with water, and finally redispersed in water.  
 
  
Morphological/structural characterization of NRs 
Scanning Electron Microscopy (SEM): The size and morphology of Pd-NPs and NRs were investigated with SEM 
(Figures S10 and S11). SEM images were acquired with a FESEM Zeiss Ultra Plus operated at 3 kV or 20 kV. 
 
 
Figure S10. (A) Representative SEM image (scale bar corresponds to 100 nm); and (B) the corresponding 
histogram of the number distribution N of the side length L of the Pd-NPs (200 particles measured) as determined 
from SEM images, L = (23.9 ± 2.0) nm. 
 
Figure S11. Representative SEM images of the NRs acquired with different detectors and different voltages: (A) 
Everhart-Thornley detector (SE2, secondary electrons) at 3 kV, (B) InLens detector (SE1, secondary electrons) at 
20 kV, and (C) AsB detector (backscattered electrons) at 20 kV. Scale bars correspond to 200 nm. (D) Histogram 
of the number distribution N of the diameter (i.e., vertex-to-vertex distance) dNR of the NRs (idealized as spherical 
particles; 100 particles measured); regions of interest (ROIs, outlines) were drawn in the SEM images to estimate 
the size of the NRs, i.e., dNR = (253 ± 12) nm.  
  
Powder x-ray diffraction (PXRD): An x-ray diffractometer Philips was used to study the crystallinity of the Pd/ZIF-
8 nanocomposites. Sample was examined in the range of 2θ between 2° and 75° with a passage of 0.02° and a 
time by step of 2s. Table S1 show the major diffraction peaks identified by PXRD (cf., Figure S12). 
 
Figure S12. PXRD spectrum of Pd/ZIF-8 nanocomposites. For comparison, simulations of ZIF-8 (black, COD - 
Crystallography Open Database: 7111970) and Pd-fcc (red; COD: 9008478) are added. Inorm is the normalized 
intensity. 
 
Table S1: Major peaks (relative intensity > 6%) identified in the Pd/ZIF-8 diffractogram. 
Pos. (°2Θ) Height (cts) FWHM Left (°2Θ) d-spacing (Å) Rel. Int. (%) 
7.37 447 0.16 11.977 100.0 
10.44 95 0.16 8.470 21.2 
12.79 209 0.15 6.918 46.6 
14.75 33 0.16 5.999 7.5 
16.52 49 0.17 5.363 11.0 
18.09 93 0.15 4.899 20.7 
24.52 30 0.16 3.627 6.6 
26.68 33 0.22 3.339 7.4 
40.13 46 0.34 2.245 10.3 
  












Dynamic light scattering (DLS) and Zeta-Potential (ζ): The hydrodynamic diameter (dh) and polydispersity index 
(PDI) of the nanocomposites were determined by DLS using a Malvern Zetasizer Nano ZSP equipped with a 10 
mW He–Ne laser operating at a wavelength of 633 nm and fixed scattering angle of 173˚. DLS spectra of the NRs 
dispersed in water freshly prepared, as well as measured over time up to one week are presented in Figure S13, 
and the corresponding dh values of the NRs both in water, cell medium (supplemented with 10% fetal bovine 
serum - FBS) and artificial lysosomal fluid (ALF, 10% FBS or without supplements) over time, are summarized in 
Table S2.  
 
Figure S13. DLS spectra, given as intensity, volume and number distributions, of NRs dispersed in water (A) freshly 
prepared, and (B) measured at different time points up to one week. 
 
  





































































































Table S2. Hydrodynamic diameters dh (mean value ± SD) as derived from DLS measurements of the NRs and Pd-
NPs dispersed in water, cell culture medium (DMEM supplemented with 10 % FBS), artificial lysosomal fluid (ALF), 
or ALF supplemented with 10 % FBS at different time points. SD values correspond to the standard deviation of 
the diameter mean value as obtained from several repetitions (n=3) of the measurement. The polydispersity index 
(PDI) values are also given.  
 
 NRs  
Time 
water cell medium ALF ALF (10% FBS) 
dh(N) (nm) PDI dh(N) (nm) PDI dh(N) (nm) PDI dh(N) (nm) PDI 
0 h 252 ± 2 0.18 299 ± 8 0.22 268 ± 3 0.14 289 ± 6 0.12 
1 h 249 ± 3 0.21 291 ± 9 0.24 273 ± 4 0.15 300 ± 7 0.21 
5 h 251 ± 2 0.22 289 ± 11 0.24 278 ± 4 0.20 295 ± 7 0.20 
24 h 252 ± 2 0.20 294 ± 10 0.30 292 ± 2 0.11 293 ± 9 0.19 
7 days 250 ± 4 0.22 301 ± 10 0.35 296 ± 3 0.19 294 ± 8 0.22 
 Pd-NP  
Time 
water cell medium ALF* ALF (10% FBS) 
dh(N) (nm) PDI dh(N) (nm) PDI dh(N) (nm) PDI dh(N) (nm) PDI 
0 h 25 ± 1 0.16 50 ± 3 0.19 376 ± 15 0.23 58 ± 2 0.15 
1 h 68 ± 2 0.20 53 ± 3 0.20 -  61 ± 3 0.21 
5 h 113 ± 3 0.24 51 ± 3 0.20 -  61 ± 4 0.20 
24 h 171 ± 10 0.27 49 ± 4 0.21 -  56 ± 3 0.19 
48 h 362 ± 24 0.39 50 ± 3 0.22 -  54 ± 3 0.19 
7 days 480 ± 25 0.41 49 ± 4 0.19 -  53 ± 4 0.20 
*Pd-NPs aggregated immediately in ALF, leading to irreversible precipitation. 
 
  
Quantification of Pd by inductively coupled plasma mass spectrometry (ICP-MS) and estimation of potentially 
active Pd 
Quantification of Pd by ICP-MS: ICP-MS measurements were performed on an Agilent 7700x inductively coupled 
plasma mass spectrometer after acidic digestion of the particles sample with aqua regia. To this end 300 µL of 
fresh aqua regia (i.e. HCl 35 wt % and HNO3 67 wt % in 3:1 volume ratio) was added to 50 L of sample solution 
(solutions of NRs or Pd nanoparticles as control; both at the same concentration), and then the samples were left 
for digestion overnight. Afterwards 4.65 mL of HCl solution (2 wt % HCl) was added prior to their injection into 
ICP-MS, being thus the total dilution sample of 100. External calibration was applied to quantify the amount of 
elemental Pd and Zn. External standards were prepared by diluting ICP-MS standards of all the ions in the same 
background solution (2 wt % HCl) as the samples, measured by triplicate and used for obtaining the external 
calibration curves.  
Results revealed that the total amount of Pd atoms used per reaction were: 8.9 µg (RSD = 1.0 %) for NRs and 9.1 
µg (RSD = 1.4 %) for Pd-NPs (Table S3). This clearly indicates that when we are carrying out equivalent reactions 
with NRs and Pd-NPs (for comparison), we are using the same amount of Pd. 
The amount of Pd per NR was determined from ICP-MS data; and considering that the empirical formula of ZIF-
8 is C8H10N4Zn, which means that 1 mol of ZIF-8 contains 1 mol of Zn. Therefore, the Pd amount in NR (i.e. Pd/ZIF-








mPd = Amount of 105Pd obtained by ICP-MS 
mZn = Amount of 66Zn obtained by ICP-MS 
MZn = Atomic mass of Zn (65.38 g/mol) 
MZIF-8 = Molecular mass of ZIF-8 (227.58 g/mol) 
Applying this equation, we obtained that the percentage of total Pd in the NR is 3.8 wt%. It was also determined 
by ICP-MS that this wt% of Pd in the NR is the same after performing the reaction, which is a clear indication of 
the stability of the NRs during the catalytic reaction.  














Pd-NPs 50 2 400  0.183  9.1 100 
NRs 50 2 400 1.296 0.179 64.8 8.9 3.8 
*Relative standard deviation (RSD) < 1.5%  
Estimation of the Pd potentially active for catalysis: Whereas ICP-MS measurements give us the total amount of 
Pd contained in the NR, it is important to note that only the Pd atoms on the surface of the Pd-NP (located in the 
center of the NR) will be able to catalyze the reactions and therefore, only this fraction of Pd (hereinafter referred 
to as surface-Pd) is potentially active. We can estimate this surface-Pd as follows (cf., Table S4). 
1) First, we calculate the number of Pd atoms contained in a Pd-NP: 
The volume of a Pd-NP (VNP) with a side length of 23.9 nm as determined from SEM images:  
VNP = L3 = (23.9 nm)3 = 1.36 × 104 nm3  
The structure is face-centered-cubic (fcc structure) with a lattice constant of 0.389 nm, being the volume of a unit 
cell (Vfcc cell)  
Vfcc cell = (0.389 nm)3 = 0.059 nm3  
Knowing that each unit cell contains 4 Pd atoms, the total number of Pd atoms in a single Pd-NP is:  
NPd, cell = (1.56 × 104 nm3) / (0.059 nm3) × 4 = 9.26 × 105 
2) Next, we calculate the number of Pd atoms on the surface of a Pd-NP: 
A Pd-NP is enclosed by 6 {100} facets, so the total surface area of a Pd-NP (Ananocube) can be calculated as:   
Ananocube = 6 × L2 = 6 × (23.9 nm)2 = 3.43 × 103 nm2 
The lattice constant of the fcc unit cell is 0.389 nm, and each two-dimensional unit cell on the {100} facets contains 
two Pd atoms. Therefore, the total number of Pd atoms on the surface of a single nanocube (NPd, surface) can be 
calculated as:  
Afcc cell = (0.389 nm)2 = 0.151 nm2  
NPd, surface = (3.43 × 103 nm2) / (0.151 nm2) × 2 = 4.54 × 104  
3) Knowing the number of NRs used for the catalytic reaction we calculate the amount of surface-Pd per reaction: 
The total amount of Pd used per reaction is 8.94 × 10-6 g as determined by ICP-MS. Thus, the total number of Pd 
atoms in the catalytic reaction is:  
NPd = (8.94 × 10-6 g) / (106.42 g/mol) × (6.02 × 1023 mol-1) = 5.06 × 1016  
The number of Pd-NPs involved in the catalytic reaction is (note that one nanocube contains 9.26 × 105 Pd atoms 
as calculated above):  
Nnanocube = (5.06 × 1016) / (9.26 × 105) = 5.46 × 1010  
Note here that owing to the architecture of the nanocomposite particle (one Pd-NP in the center of one NR), the 
number of NRs involved in the reaction is the same as the number of Pd-NPs.  
Thus, the actual concentration of NRs used per reaction (total volume 400 µL) is: 
nNR= (5.46 × 1010) / (6.022 × 1023) = 9.07 × 10-14 mol of NR 
CNR = (9.07 × 10-14) / (4 × 10-4) = 2.3 × 10-10 M = 0.23 nM 
Regarding the fraction of Pd potentially active, the total number of Pd atoms on the surface of Pd-NPs used in 
the catalytic reaction is:  
Ntotal surface-Pd = (4.77 × 1010) × (4.96 × 104) = 2.71 × 1015  
ntotal surface-Pd = (2.71 × 1015) / (6.022 × 1023) = 4.5 × 10-9 mol of surface-Pd 
As the total volume of the reaction is 400 µL, the concentration of surface Pd in the reaction is ~10 µM. 
 
















Pd NPs 1.36·104 0.059 9.26·105 3.43·103 0.151 4.54·104 9.14 3.78·10-5 10.1 
NRs 1.36·104 0.059 9.26·105 3.43·103 0.151 4.54·104 8.94 3.69·10-5 9.8 
*Each unit cell with fcc structure contains 4 Pd atoms 




Evaluation of porous accessibility/porosity of NRs  
The porosity and possibility of diffusion-controlled flow of molecules through the porous of the ZIF-8 shell in the 
NRs was evaluated using model fluorescent probes. To this end, NRs were incubated with two fluorescent probes: 
TAMRA (tetramethylrhodamine 5-(and-6)-carboxamide cadaverine) and DOX (doxorubicin); and the amount 
loaded probes was quantified by fluorescence. NRs as dispersed in water (100 µL, 1 nM) were mixed with a 
solution of fluorescent probes in MeOH (10 µL, 1.5 mM), having thus 1.5×105 probe/NC during the incubation, 
and the mixture was incubated for 4 h at r.t. Afterwards, the NRs were quickly collected by centrifugation (1 min, 
10,000 RCF), and the loaded fluorescent molecules were determined after digestion/destruction of the NRs in 
order to avoid errors in the quantification associated to potential fluorescence quenching and/or 
scattering/turbidity interference. For the digestion, the pellet of NR containing the fluorescent molecules were 
treated with 40 µL of 2% HCl solution for 15 min. Then, 10 µL of 2 M NaOH solution was added to neutralize the 
medium, plus 250 µL of water, and fluorescence measurement of this mixture was performed. The concentration 
of TAMRA or DOX loaded was determined by interpolation of the measured fluorescence intensity (I) to a 
previously constructed analytical calibration curve (Figure S14). This led to a value (mean ± standard deviation, 
n=2) of 4.24×104 ± 8.29 ×102 TAMRA per NR and 7.58×104 ± 6.25 ×102 DOXO per NR (Table S5). 
 
Figure S14. Calibration curves of TAMRA (A) and DOX (B) in water obtained from fluorescence measurements: 
for TAMRA λexc/λem=550/580 nm and for DOXO λexc/λem=480/588 nm. Fluorescence intensity (I) at the maximum 
emission peak as a function of HOE concentration c is plotted and calibration equation is obtained by fitting a 
linear regression line to the collected data; R2 is the coefficient of determination. 
 







TAMRA 1.5·105 4.24·104 ± 8.29·102 28.3 ± 0.8 
DOX 1.5·105 7.58·104 ± 6.25·102 50.5 ± 0.6 
 
  

































General procedures of the depropargylation reactions 
Depropargylation of substrates 1 and 3 promoted by NR or Pd-NPs: 1 or 3 (8 µL, 0.5 mM stock solution in MeOH) 
was added to a H2O:MeOH 9:1 solution (342 µL) in a 1.5 mL HPLC vial (containing a stirring bar) followed by 
addition of an aqueous solution of Pd-NPs or NRs (50 µL, 2 nM; this corresponds to 10 µM of surface-Pd). The 
influence of the catalyst concentration was also evaluated by varying the amount of the aqueous solution of Pd-
NPs or NRs added. The vial was sealed with a screw cap and the reaction mixture was stirred (400 rpm) at 37 ºC. 
After overnight (15 h), NRs were collected by centrifugation (7000 RCF, 10 min), and the supernatant was 
separated. The precipitate was washed once with 400 µL of a 9:1 H2O:MeOH solution, centrifuged again (7000 
RCF, 10 min), and the supernatant was separated and mixed with the first supernatant. Finally, this supernatant 
was analyzed by fluorescence to quantify the obtained amount of 2 or 4 respectively (Table S6, Figure S15), cf. 
calibration curves in Figure S3. 
Depropargylation of substrate 5 promoted by NR: 5 (8 µL, 0.5 mM stock solution in MeOH) was added to a 
PBS:MeOH 8:2 solution (342 µL) in a 1.5 mL HPLC vial (containing a stirring bar) followed by addition of an 
aqueous solution of NRs (50 µL, 2 nM; this is the concentration of NRs). The vial was sealed with a screw cap and 
the reaction mixture was stirred (400 rpm) at 37 ºC. After overnight (15 h), the NRs were collected by 
centrifugation (7000 RCF, 10 min), and the supernatant was separated. The precipitate was washed once with 400 
µL of a 8:2 PBS:MeOH solution, centrifuged again (7000 RCF, 10 min), and the supernatant was separated and 
mixed with the first supernatant. Finally, this supernatant was analyzed by fluorescence to quantify the amount of 
6 obtained (Table S6, Figure S15), cf. calibration curve in Figure S6. 
Depropargylation of substrate 1 in the presence of 3 promoted by NR: 1 (8 µL, 0.5 mM stock solution in MeOH) 
and 3 (8 µL, 0.5 mM stock solution in MeOH) were added to a H2O:MeOH 9:1 solution (334 µL) in a 1.5 mL HPLC 
vial (containing a stirring bar) followed by addition of an aqueous solution of NRs (50 µL, 2 nM; this is the 
concentration of NRs). The vial was sealed with a screw cap and the reaction mixture was stirred (400 rpm) at 37 
ºC. After overnight (15 h), the NRs were collected by centrifugation (7000 RCF, 10 min), and the supernatant was 
separated. The precipitate was washed once with 400 µL of a 9:1 H2O:MeOH solution, centrifuged again (7000 
RCF, 10 min), and the supernatant was separated and joined with the first supernatant. Finally, this supernatant 
was analyzed by fluorescence to quantify the obtained amount of 2 and 4 (Table S6), cf. calibration curve in Figure 
S9. 
  
Table S6 Reaction conditions and yields of the depropargylation of several substrates promoted by NRs or Pd-
NPs; as control, we also used ZIF-8 nanoparticles without the Pd core. 
Catalyst 
type 










NRs 1 H2O:MeOH 9:1, 37 ºC, 15h  1 10 2 3.70 ± 0.08 37.0 ± 1.2 
NRs 5 H2O:MeOH 9:1, 37 ºC, 15h  1 10 2 8.92 ± 0.14 89.2 ± 1.4 
NRs 10 H2O:MeOH 9:1, 37 ºC, 15h  1 10 2 9.70 ± 0.13 97.0 ± 1.3 
NRs 15 H2O:MeOH 9:1, 37 ºC, 15h  1 10 2 9.85 ± 0.15 98.5 ± 1.5 
NRs 10 PBS:MeOH 9:1, 37 ºC, 15h   1 10 2 9.20 ± 0.14 92.0 ± 1.4 
Pd-NPs 10 H2O:MeOH 9:1, 37 ºC, 15h  1 10 2 1.90 ± 0.45 19.0 ± 4.5 
ZIF-8# 0 H2O:MeOH 9:1, 37 ºC, 15h  1 0 n.r.* n.r.* n.r.* 
NRs 10 H2O:MeOH 9:1, 37 ºC, 15h  3 10 n.r.* n.r.* n.r.* 
Pd-NPs 10 H2O:MeOH 9:1, 37 ºC, 15h  3 10 4 1.54 ± 0.18 15.4 ± 1.8 
NRs 10 H2O:MeOH 9:1, 37 ºC, 15h  1+3 10+10 2 5.40 ± 0.37 54.0 ± 3.7 
NRs 10 PBS:MeOH 8:2, 37 ºC, 15h   5 10 6 8.23 ± 0.10 82.3 ± 1.0 




Figure S15. (A) Photographs under visible and UV light of the reaction mixture for the depropargylation reaction 
of 1 (A1) or 5 (A2) promoted by NRs taken before and after the reaction. (B) Photographs under visible light of 
the reaction mixture for the depropargylation reaction of 1 promoted by Pd NPs taken before and after the 
reaction, where aggregation of Pd-NPs is observed. Scale bars correspond to 100 nm.  
 
Calculation of turnover number (TON): As it was calculated in a previous section, the concentration of the catalyst 
(surface-Pd) used in the reaction under the optimized conditions was 10 µM. Knowing that the total volume of 
the reaction is 400 µL, this corresponds to 4 × 10-9 mol of catalyst per reaction. The calculation of the yield of the 
reactions, and therefore, the amount of substrate converted to the desired product, allows us to calculate the 
TON by using the following equation: 
TON= 
moles of desired product formed
moles of catalyst
 
We determined the TON values as function of the amount of catalyst used and maintaining constant the amount 
of substrate (see Table S7). 
  
Table S7. TON values of the reaction for the depropargylation reaction of 1 and 5 by using different amounts of 
NRs. In all cases the reactions were carried out overnight at 37 ºC, except in one case where the reaction was 
performed for 7 days. 
[Catalyst] 
(µM surface Pd) 






15 1 10 37 ºC, 15 h 98.5 ± 1.5 9.85 ± 0.15 0.66 ± 0.01 
10 1 10 37 ºC, 15 h 97.0 ± 1.3 9.70 ± 0.13 0.97 ± 0.01 
5 1 10 37 ºC, 15 h 89.2 ± 1.4 8.92 ± 0.14 1.78 ± 0.04 
1 1 10 37 ºC, 15 h 37.0 ± 1.2 3.70 ± 0.08 3.70 ± 0.11 
1 1 10 37 ºC, 7 d 99.6 ± 1.1 9.96 ± 0.11 9.96 ± 0.15 
15 5 10 37 ºC, 15 h 90.8 ± 1.5 9.08 ± 0.15 0.60 ± 0.01 
10 5 10 37 ºC, 15 h 82.3 ± 1.0 8.23 ± 0.10 0.82 ± 0.01 
5 5 10 37 ºC, 15 h 65.6 ± 1.2 6.56 ± 0.12 1.31 ± 0.03 
1 5 10 37 ºC, 15 h 26.6 ± 0.9 2.66 ± 0.09 2.66 ± 0.13 
 
Influence of the washing step after reaction: In order to minimize the number of steps in the general procedure 
for the determination of the product generated, the influence of the washing step after the reaction was 
evaluated. As described above, the general procedure consisted of separating the NRs by centrifugation after 
the reaction, washing them once with the same medium used for carrying out the reaction, and finally determining 
the amount of product formed by measuring the fluorescence in the total supernatant. The need of this washing 
step was evaluated by performing the procedure with and without this additional washing step. The obtained 
data are presented in Table S8 in which it is clear that depending on the substrate (1 or 5), and thus of the 
retention of the generated product within the pores of the ZIF-8 structure (i.e., hydrophobicity/hydrophilicity, 
polarity, and so on), this step of washing is important for achieving a quantitative determination or not. 
Table S8. Effect of washing step on the quantitative yield determination of the depropargylation of two 










without washing with washing 
NCs 10 1 10 2 93.0 ± 3.8 97.0 ± 1.3 
NCs 10 5 10 6 60.0 ± 6.1 85.7 ± 2.8 
  
Leaking of Pd during the depropargylation of substrate 1: The stability of the Pd-NPs inside the ZIF-8 structure 
was studied by evaluating the potential leaking of Pd from the NRs during the reaction. To this end, the reaction 
was performed under the optimized conditions described above (used during the reaction of 1 as model) and the 
amount of Pd released to the supernatant after the reaction was quantified by ICP-MS. For comparison the same 
was done with the CTAB-protected Pd-NPs. Data presented in Table S9 are expressed in ppm (i.e., mg/L), 
showing that the amount of Pd released was much higher in the case of working with Pd-NPs while the leaching 
in the case of NRs was negligible. As we know the amount of total Pd in both Pd-NPs and NRs, the amount of 
released Pd was also expressed as percentage of the total Pd. These results clearly indicate that the Pd-NPs are 
well protected inside the ZIF-8 structure, avoiding not only their potential passivation by biomolecules as 
demonstrated above, but also their surface damage leading to the irreversible leaching of Pd from the catalyst. 
Table S9 Leaking of Pd (ppm of Pd released) during the depropargylation reaction of 1 depending on the catalyst 







% Pd released 
NRs 10 0.146 ± 0.011 0.081 ± 0.008 
Pd-NPs 10 30.4 ± 2.0 16.6 ± 1.1 
 
Reusability of NRs: In order to investigate the potential reuse of the NRs, after the reaction the NRs were collected 
by centrifugation, washed twice with water to remove potential remaining substrate/products, and redispersed 
in a fresh aqueous solution containing the substrate for a new run. The supernatants from each use were measured 
by fluorescence to quantify the amount of generated product. Using the substrate 1 the same procedure was 
carried out with Pd-NPs in order to compare the stability of NRs with that of Pd-NPs. Data presented in Table 
S10 clearly shows that the loss of efficiency of the NRs for promoting the depropargylation reaction was negligible 
after four runs.  
Table S10 Yields of the depropargylation of two different substrates promoted by NRs or Pd-NPs after successive 









Yield (%) / Run number 
1 2 3 4 
NRs 10 1 10 2 97.0 ± 3.1 96.1 ± 2.5 98.0 ± 2.1 95.4 ± 3.4 
Pd-NPs 10 1 10 2 19.0 ± 1.5 9.2 ± 2.1 5.0 ± 2.8 2.1 ± 2.7 
NRs 10 5 10 6 80.3 ± 2.9 81.1 ± 3.2 77.9 ± 4.7 71.0 ± 6.1 
  
Kinetic of the depropargylation reaction 1 2: To study the kinetic of the reaction of the substrate 1, the reaction 
was evaluated as a function of time. Several reactions were carried out in parallel under identical conditions and 
each one was stopped at different time points. To this end, 1 (8 µL, 0.5 mM stock solution in MeOH) were added 
to a H2O:MeOH 9:1 solution (342 µL) in a 1.5 mL HPLC vial (containing a stirring bar) followed by addition of an 
aqueous solution of NRs (50 µL, 2 nM; this is the concentration of NRs). The vial was sealed with a screw cap and 
the reaction mixture was stirred (400 rpm) at 37 ºC. After different times, the reaction was stopped and the NRs 
were collected by centrifugation (7000 RCF, 10 min), and washed once with 400 µL of a H2O:MeOH 9:1 solution. 
All the supernatants were collected and the fluorescence from product 2 was measured. The fluorescence 
intensity of 2 was plotted versus the time (see Figure S16) to obtain the kinetic curve. Moreover, the kinetic of 
the reaction of substrate 1 was evaluated also in the presence of 3 as interference, knowing that the 
depropargylation of substrate 3 is not promoted by the NRs. In this case 10 µM of 3 (8 µL, 0.5 mM stock solution 
in MeOH) was added together with 10 µM of 1 (8 µL, 0.5 mM stock solution in MeOH) to the reaction mixture. 
 
Figure S16. Kinetics of the depropargylation of substrate 1, either by mixing NR with 1 in the absence (green) or 
presence of 1 eq. of 3 (light green). Dashed lines correspond to logistic fitting curves obtained with Originlab; R2 
>0.99. 
In order to figure out a potential reason of the fact that the substrate 3 is not catalyzed by NRs, and additionally 
not only slow down the kinetic reaction of 1 but also it seems that a change of the slope in the kinetic curve takes 
place from 10 h, we carried out studies of the NRs after reaction by DLS and Z-Potential. As shown in Table S11, 
after the reaction of NRs with substrate 3 the hydrodynamic size of the NRs increased, and a decrease of the 
negative charge was also observed. This could be attributed to a binding of some molecules of substrate 3 on 
the surface of NRs, avowing their diffusion into the NR core, and also partially blocking the diffusion of substrate 




















Table S11. Hydrodynamic diameters dh (mean value ± SD) as derived from DLS measurements of the NRs 
dispersed the reaction mixture before reaction and after reaction with substrate 1 or 3 in H2O/MeOH 9:1. SD 
values correspond to the standard deviation of the diameter mean value as obtained from several repetitions 




After reaction with 
1 3 
dh (nm) 249 ± 3 252 ± 4 306 ± 3 
PDI 0.10 0.12 0.11 
ζ (mV) -34.5 ± 0.5 -34.4 ± 0.8 -26.5 ± 0.7 
 
Performance of the NRs as “continuous” nanoreactors: The performance of the NRs for promoting the 
depropargylation reaction of 5 by in three successive steps was studied as follows: for 1 cycle, 5 (8 µL, 0.5 mM 
stock solution in MeOH) was added to a PBS:MeOH 8:2 solution (342 µL) in a 1.5 mL HPLC vial (containing a 
stirring bar) followed by addition of an aqueous solution of NRs (50 µL, 2 nM; this is the concentration of NRs). 
The vial was sealed with a screw cap and the reaction mixture was stirred (400 rpm) at 37 ºC. After 18 h, the NRs 
were collected by centrifugation (7000 RCF, 10 min), and the supernatant was separated. The precipitate was 
washed once with 400 µL of a 8:2 PBS:MeOH solution, centrifuged again (7000 RCF, 10 min), and the supernatant 
was separated and mixed with the first supernatant. The generated product in the supernatant was measured by 
fluorescence. For 2 successive cycles, the reaction was carried out in identical conditions and after 18 h, instead 
of purified the product, another shot of 5 (8 µL, 0.5 mM stock solution in MeOH) was added to the reaction 
mixture. The mixture was left to react 18 h, with stirring and at 37 ºC, and afterwards the total generated product 
was separated and quantify as described in first cycle. The same was repeated with one more addition for 3 cycles. 
Results are presented in Table S12. 












NRs 10 1  10 2 94.6 ± 5.3 
NRs 10 2  10 + 10 2 178.4 ± 6.8 
NRs 10 3  10 + 10 + 10 2 250.6 ± 8.1 
Reverse phase high-performance liquid chromatography- diode array detector/mass spectrometry (RP-HPLC-
DAD/MS) characterization of the NR-promoted depropargylation of the cresyl violet 5: The depropargylation 
reaction of substrate 5 promoted by NR was carried out in slightly different conditions as described above in the 
general procedures section, in order to obtain the product 6 concentrated enough for their posterior analysis. 
Specifically, the substrate solution (8 µL, 0.5 mM stock solution in MeOH) was added to a PBS:MeOH 1:1 solution 
(342 µL) in a 1.5 mL HPLC vial (containing a stirring bar) followed by addition of an aqueous solution of NRs (50 
µL, 2 nM; this is the concentration of NRs). The vial was sealed with a screw cap and the reaction mixture was 
stirred (400 rpm) at 37 ºC. This was performed in parallel in 5 vials. After overnight (15 h), the NRs were collected 
by centrifugation (7000 RCF, 10 min), and the supernatants were separated. The precipitates were washed once 
with 400 µL of MeOH solution, centrifuged again (7000 RCF, 10 min), and all the supernatants from the different 
vials were mixed. This supernatant was preconcentrated by evaporation of the MeOH solvent, and 100 µL of 
DMSO was added to avoid the precipitation of the product and unreacted substrate. Finally, this supernatant was 
analyzed by RP-HPLC-DAD/MS, and as controls the pure substrate and product were also analyzed (Figure S17).  
 
Figure S17. RP-HPLC-DAD chromatogram (left) and ESI-MS spectra (right) of compound 5, RP-HPLC-DAD 
chromatogram (left) and ESI-MS spectra (right) of compound 6, and RP-HPLC-DAD chromatogram (left) of the 
obtained reaction mixture promoted by NRs.  
Performance of the reactions in the presence of bio-additives 
Reaction of substrate 1 in the presence of additives: The reaction was carried out as described in the previous 
section, but adding the following additives (Table S13): (i) different amounts of BSA (for a final concentration in 
the total volume of 40 µM, 80 µM, or 150 µM); (ii) DMEM (supplemented with 10 % FBS), and in this case the 
reaction was studied after 15 h and 72 h; (iii) 5 mg/mL of cell lysate. 
Reaction of substrate 5 in the presence of additives: The reaction was carried out as described in the previous 
section, but adding the following additives (Table S13): (i) different amounts of BSA (for a final concentration in 
the total volume of 40 µM, 80 µM, or 150 µM); (ii) 5 mg/mL of cell lysate. 
Cell Lysate preparation: For the preparation of the HeLa cells lysates, 3x106 exponentially growing HeLa cells 
were washed twice with PBS, scrapped with a rubber policeman in 0.5 mL of PBS, and sonicated intensely for 2 
rounds of 1 min with a 30 second cooling period in between. The protein concentration of the lysates was 
quantified by DCTM Protein Assay (BioRad) and equalised to 10 mg/mL for reproducibility among experiments. 
 
Table S13. Reaction yields of the depropargylation of two substrates promoted by NRs or Pd-NPs in the presence 
of different bioadditives.  
Catalyst 
type 








NRs 10 - 1 10 2 97.0 ± 1.3 
NRs 10 BSA, 40 µM 1 10 2 55.0 ± 3.0 
NRs 10 BSA, 80 µM 1 10 2 53.0 ± 2.9 
NRs 10 BSA, 150 µM 1 10 2 33.0 ± 3.5 
Pd-NPs 10 - 1 10 2 19.0 ± 1.5 
Pd-NPs 10 BSA, 40 µM 1 10 2 9.0 ± 1.6 
Pd-NPs 10 BSA, 80 µM 1 10 2 7.0 ± 2.0 
Pd-NPs 10 BSA, 150 µM 1 10 2 7.0 ± 2.1 
NRs 10 DMEM, 10%, 15h 1 10 2 22.0 ± 3.2 
NRs 10 DMEM, 10%, 72h 1 10 2 47.0 ± 3.7 
NRs 10 Lysate, 5 mg/mL 1 10 2 19.0 ± 2.8 
NRs 10 - 5 10 6 84.8 ± 2.5 
NRs 10 BSA, 20 µM 5 10 6 62.8 ± 2.3 
NRs 10 BSA, 40 µM 5 10 6 54.1 ± 2.9 
NRs 10 BSA, 8 µM 5 10 6 23.8 ± 3.9 
NRs 10 Lysate, 5 mg/mL 5 10 6 22.5 ± 4.1 
  
Cell studies 
Cell culture: HeLa (cervical cancer cell line) were cultured in Dulbecco’s Modified Eagle´s Medium with phenol 
red, 4.5 g/L D-glucose, L-glutamine and pyruvate (DMEM, 1X, Gibco, #41966-029) supplemented with 10% Fetal 
Bovine Serum (Gibco, #10270-106) and 1% Penicillin Streptomycin (P/S, Corning, 100X, #30-002-CI). Cells were 
maintained under humid conditions at 37 °C and 5% of CO2. Cells were passaged after cleaning Dulbecco’s 
Phosphate Buffered Saline (DPBS, 1X, Gibco, #14190-094) with 0.25% Trypsin-EDTA (1X, Gibco, 25200-056) when 
the culture reached confluency.  
Cell Viability: In order to study number of viable cells after the exposure to the substrates, Pd-NPs and/or NRs, 
we carried resazurin assays (Figure S18). HeLa cells were seeded in 96-well plates (NEST Scientific, #701001), 
7.5·103 cells per well in 100 µL of cell growth medium (0.3 cm2 per well) 24 h before the exposition. Then media 
was removed and 100 L of cell culture growth medium with the desired concentration of the substrates, Pd-NPs 
and/or NRs s were added. The cells were incubated with the samples the time of interest at 37 °C and 5% CO2. 
After that, we rinsed each well three times with PBS and added 100 µL of freshly prepared solution with 90% of 
media and 10% of resazurin (resazurin sodium salt in water 0.2 mg/mL filtered; Resazurin Sodium Salt, Sigma 
Aldrich, #199303-1G). Cells were incubated at 37 °C and 5% CO2 under dark conditions. 
Non-fluorescent resazurin (Alamar blue) is oxidized by living cells into its fluorescent product resorufin (excitation 
at 579 nm and emission at 584 nm). In this way, the fluorescence intensity of each well is proportional to the 
number of living cells there. After the incubation time, plates were measured with a plate reader (Infinite® 200 
PRO, Tecan, Switzerland) under 560±20 nm excitation and collecting fluorescence with a 610±20 nm filter. The 
fluorescence value of each well provided by the instrument is an average of nine consecutive measures in the 
same well. Final intensity value for control cells (IC), the ones that were not treated, is an average of, at least, nine 
different well values. Final intensity values for samples (IS) are a mean of three independent well values. So, we 
can calculate the final cell viability values as: 




Pd content per cell. ICP-MS was used to quantify the average Pd content per cell, which we used to estimate the 
number of Pd-NPs or NRs per cell (Table S14); see calculations in Section IV “Quantification of Pd by inductively 
coupled plasma mass spectrometry (ICP-MS) and estimation of Pd potentially active”. Note that to estimate the 
number of particles per cell, we assume that the particles (Pd-NPs or NRs) retain their original Pd content; 
however, in contrast to the Pd-NPs, such assumption seems valid for the NRs according to the stability data (Table 
S2). HeLa cells (~6.4·106 cell per experiment) were cultured as previously discussed, supplemented with Pd-NPs 
or NRs (50 pM  2 µM in surface Pd, equivalent to ~5.7·103 particles per cell), and incubated overnight. 
Extracellular Pd (either free, Pd-NP or NRs) were washed out, and the Pd-loaded cells were digested with aqua 
regia (see detailed procedures in previous work10). 
 
Table S14. Amounts of Pd per cell and particle uptake % (measured-to-added) as derived from ICP-MS 
measurements.  
Particle 






Pd per  
cell (µg) 




Pd-NPs 1.7·1010 6.5·105 5.6·103 1.2·10-8 ± 8.9·10-11 71 ± 1 0.5 
NRs 1.7·1010 6.3·105 5.8·103 2.0·10-8 ± 2.5·10-10 120 ± 1 0.8 
*See section S4. 
#Assuming particles retain their Pd original content inside cells. 
 
Confocal imaging: In order to perform all the confocal imaging experiments with living cells, 20·103 HeLa cells 
(200 µL) were seeded on µ-Slide 8 well-ibiTreat chambers (1 cm2 per well, Ibidi, Germany, #80826) at least 12 h 
before NR/substrate exposure. Organelle staining with LysoTracker Blue (#L7525), MitoTracker Green (#M7514) 
and CellMask Deep Red (#H32721) was performed following provider (Thermo Fisher Scientific) instructions. 
Confocal images of living cells were captured on an Andor Dragonfly spinning disk confocal system mounted on 
a Nikon TiE microscope equipped with a Zyla 4.2 PLUS camera (Andor, Oxford Instruments) and an OKO-lab 
incubator to keep cells at 37 °C during all the experiment. Images were taken with different magnification 
objectives (60x, 100x). All the images were processed with ImageJ. 
Confocal microscopy images of the NR system in which PMA was fluorescently labeled (covalently) with a 
rhodamine (tetramethylrhodamine 5-(and-6)-carboxamide cadaverine),9 are shown in Figure S19, aiming to 
illustrate the efficient cell internalization (HeLa cells) of the proposed NRs (50 pM) and colocalization with 
lysosomes. Note that we used equivalent particle (NR or Pd-NP) incubation conditions in all the cell studies. 
Excitation/Emission wavelengths used for confocal imaging of the rhodamine-labeled NRs/product 6 are 
561/620(60). 
 
Depropargylation reactions inside cells. Different concentrations of the substrate 5 (Figure S20-21) were added 
to cells pretreated with NRs or Pd-NPs (50 pM, overnight). The productions of 6 was inspected by checking the 
intracellular fluorescence after the time of interest (1-24 h). 
For the study of the depropargylation of 5 over time (Figure S21-24), we preload the cells with the NR (50 pM) 
overnight and, after three washing steps with PBS to remove the excess of NR non-associated with cells, substrate 
5 (10 µM) was added with fresh medium. We incubated the substrate 5 during 1, 3, 6 and 24 h. Washing steps to 
remove extracellular excess of 5 and or 6 were not required before confocal inspection. 
Controls were carried with the same concentrations of 5 but with Pd-free cells (Figure S25). 
We also confirmed that Pd-NPs (50 pM  2 µM in surface Pd, overnight) without the MOF shell, or a series of 
discrete Pd complexes (Pd-1, Pd-2 and Pd-3; 2 µM Pd, overnight), promote the intracellular depropargylation of 
the substrate 5 (Figure S26), although with much less efficiency than the NRs (Figure S21-24). 
 
Intracellular recycling. In order to study the reusability of our cell-nanoreactor for the depropargylation of 5, we 
stopped the incubation of the substrates with NR-preloaded cells after the time of interest (substrate 5: 20 µM, 3 
h). Then, the intracellular production of 6 was inspected under the microscope; notice that washing to remove 
extracellular substrates/products step was not required for visualizing the depropargylation of 5.  
Next, before adding a second shot of 5 (10 µM, 3 h), we cleaned with PBS, added fresh complete DMEM and 
waited for the cells to “wash away” 6 (~ 3 h, cleansing). We repeated these steps to complete up to four cycles 
(Figure S27).  
As controls for the recycling experiments, we also performed similar studies for the depropargylation of 5 (two 
runs) but using Pd-NPs (50 pM  2 µM in surface Pd, overnight) or the discrete Pd complexes (Pd-1, Pd-2 or Pd-
3; 2 µM Pd, overnight). However, such alternative Pd catalysts were unable to achieve a second depropargylation 
cycle, at least to any degree observable by the intracellular fluorescence of 6 (Figure S26). 
 
Depropargylation and recycling in 3D NR-preloaded HeLa spheroids. Spheroids of HeLa cells were cultured in 96 
well plates previously treated with agarose as follows:11 a 1% agarose solution in filtered PBS was heated until 
100 ºC; the tips and the 96-well plate was pre-warmed in the incubator for ~ 1 h, and 40 µL of the agarose solution 
were added to each well; the agarose filled wells were led to cool down during, at least, 30 minutes in sterile 
conditions. Then, we confirmed a homogeneous agarose gelation without bubbles by inspection under the 
microscope. Once agarose was solidified, 100 µL of cells (NR-preloaded or “empty”) solution at different 
concentrations were added slowly. Cells were led to attach to each other during 24 hours before checking the 
spheroids formation. After 24 h, the sizes of spheroids were between 0.4 and 1 µm when varying total cells 
amounts from ~ 1·104 to 3·104 cells per spheroid (Figure S28). Media of the wells containing the spheroids were 
changed daily. 
For spheroids imaging, spheroids formed as previously discussed were placed onto a µ-plate angiogenesis 96 
well (0.125 cm2 per well, Ibidi, Germany #89646) using a pipette with a sterile cut tip to facilitate the spheroid´s 
manipulation. Using an Andor Dragonfly spinning disk confocal system with the 20x objective, spheroids were 
observed in the brightfield channel (Figure S28) and in the Cy3 channel (wavelengths: excitation 561 nm; emission 
620(60) nm) where the fluorescence from TAMRA (Figure S29) or from the depropargylation of 5 (Figure S30) 
were collected. For the bigger ones (~ 1 µm in diameter), 4 different images in the plane XY were required. Z-
scans were made with ~ 300 different stack images in the Z axis. 3D reconstructions were done with ~ 300 stack 
images (total thickness ~ 150 µm; step thickness ~ 0.5 µm). Scale bars correspond to 100 µm (20x). In order to 
treat the 2D images as well as to crop or stitch 4x4 images, ImageJ was used. Deconvolution of the z-scans were 
done with Fusion software and finally, for 3D reconstructions, Imaris software (Oxford Instruments) was used. 
In order to form spheroids with catalytic properties, 2·104 cells per well were seeded on 6 well plates. After 24 
hours of cell attachment, cells were treated with the NRs (50 pM, overnight) as previously discussed. Notice that 
non-treated cells were always seeded and maintained as control, to form control non-catalytic spheroids. Once 
the NR were internalized, extracellular NRs were washed three times with fresh PBS. Cells were trypsinized with 
200 µL of trypsin and neutralized with 2 mL of DMEM (10% FBS). After that, dilutions were made to obtain the 
desired number of cells in 100 µL. After one day of spheroids formation, the medium was removed and fresh 
medium containing 5 (20 µM) was added to both NR-loaded spheroids and control spheroids without NRs (Figure 
S30). After 24 hours, spheroids were checked under the confocal microscope. Media was removed and the 
spheroids were thoroughly washed (3x) with PBS to remove extracellular substrates and/or products and fresh 
medium was added, which facilitated the cleansing of 6 during 24 h. After cleansing, a second addition of 5 (24 




Figure S18. Cell viability using the resazurin assay of HeLa cells exposed to increasing concentrations of reactant(s) 
and/or NRs and/or Pd-NPs. Half-maximal responses (EC50 values) were estimated by fitting (Dose Response 
function in OriginLab). a) Pd-NPs (50 pM), 24 h incubation; b) NRs (50 pM), 24 h incubation; c) 5, 24 h incubation; 
d) 6, 24 h incubation; e) 5, 24 h incubation with Pd-NPs (50 pM)-preloaded cells; f) 5, 24 h incubation with NR (50 
pM)-preloaded cells; g) 5, 3 h incubation with NR (50 pM)-preloaded cells; h) 5, 6 h incubation with NR (50 pM)-
preloaded cells; i) 5, 9 h incubation with NR (50 pM)-preloaded cells; j) comparison between the incubation (24 h) 
of 6 with Pd-free cells and 5 with NR (50pM)-preloaded cells.  
 
Figure S19. Collage of confocal microscopy images. a1,a2,a3) Rhodamine-labelled NRs (pink); b1,b2,b3: 
Rhodamine-labelled NRs (pink) + LysoTracker® Blue (cyan); c1,c2,c3) Display of colocalization of NR and 
LysoTracker® Blue (Pearson correlation coefficient: 0.42 ± 0.05, n=5); d1,d2,d3) LysoTracker® Blue + 
MytoTracker® Green + CellMaskTM Deep Red; e1,e2,e3: d1,d2,d3 + rhodamine-labelled NRs (pink); f1,f2,f3: 
Display of colocalization of NR and MitoTracker® Green (Pearson correlation coefficient: -0.23 ± 0.04, n=5) . Scale 
bars correspond to 40 µm. Colocalization analysis in fluorescence was performed with ImageJ (Coloc 2 Fiji's plugin 




Figure S20. Collage of confocal microscopy images (left: pink channel; right: merged pink + bright-field; 60x) for 
the production of 6 after 6 h incubation with NR-preloaded cells (using 2.5 µM of 5); a1-a2) controls without NRs; 
b1-b2) two examples using NR-preloaded cells as previously discussed. Scale bars correspond to 40 µm. 
  
 
Figure S21. Collage of confocal microscopy images (left: pink channel; right: merged pink + bright-field; 60x) for 
the production of 6 after 1 h incubation with NR-preloaded cells (using 10 µM of 5); a1-a2) controls without NRs 
(a1: 60x; a2: 100x); b1-c1) two examples using NR-preloaded cells as previously discussed (60x); b2-c2) two 




Figure S22. Collage of confocal microscopy images (left: pink channel; right: merged pink + bright-field; 60x) for 
the production of 6 after 3 h incubation with NR-preloaded cells (using 10 µM of 5); a1-a2) controls without NRs 
(a1: 60x; a2: 100x); b1-c1) two examples using NR-preloaded cells as previously discussed (60x); b2-c2) two 




Figure S23. Collage of confocal microscopy images (left: pink channel; right: merged pink + bright-field; 60x) for 
the production of 6 after 6 h incubation with NR-preloaded cells (using 10 µM of 5); a1-a2) controls without NRs 
(a1: 60x; a2: 100x); b1-c1) two examples using NR-preloaded cells as previously discussed (60x); b2-c2) two 





Figure S24. Collage of confocal microscopy images (left: pink channel; right: merged pink + bright-field; 60x) for 
the production of 6 after 24 h incubation with NR-preloaded cells (using 10 µM of 5); a1-a2) controls without NRs 
(a1: 60x; a2: 100x); b1-c1) two examples using NR-preloaded cells as previously discussed (60x); b2-c2) two 




Figure S25. Collage of confocal microscopy images (left: fluorescence channel; right: merged fluorescence + 
bright field; 60x and 100x) for the incubation of 6 with Pd-free cells; cells were incubated with 6 (0.2 µM) for ~1 
h. Before microscope inspection, cells were washed to remove extracellular probes. Scale bars correspond to 20 
µm (100x) or 40 µm (60x). 
 
Figure S26. Collage of confocal microscopy images (left: pink channel; right: merged pink + bright-field; top: first 
generation run; bottom: second generation run using the same catalyst-preloaded cells) for the production of 6, 
using cells preloaded with (a) NR (50 pM  2 µM in surface Pd, overnight), (b) Pd-NP (50 pM  2 µM in surface 
Pd, overnight), of discrete Pd complexes (c) Pd-1, (d) Pd-2, or (e) Pd-3, which were incubated with 5 (10 µM) for 
~ 6 h before microscope inspection. f) Control experiments using “empty” cells (Pd “free” cells). Scale bars 
correspond to 20 µm. All these experiments were carried out using exactly the same experimental conditions.
 
Figure S27. Collage of confocal microscopy images (left: pink channel; right: merged pink + bright-field). a) 
Control without NRs and the addition of substrate 5 (20 µM). b-g) First, second and third generation runs using 
the same NR-preloaded cells and recorded by confocal microscopy; b,d,f) generation of 6 after 3 h incubation of 
5 (20 M); c,e,g) 3 h cleansing. h) fourth reaction cycle. Scale bars correspond to 20 µm. 
  
 
Figure S28. Collage of brightfield images of 3D HeLa (Pd “free” spheroids). a) HeLa spheroid with diameter ~ 0.4 
µm (1 image per stack); b) Three different stacks of the spheroid shown in a. c) HeLa spheroid with diameter ~ 1 
µm (4 images in each plane); d) Three different stacks of the spheroid shown in c. e) 3D reconstruction (top-view) 
of a spheroid with diameter ~ 0.4 µm. Scale bars correspond to 100 µm.  
 
Figure S29. Collage of confocal images of 3D spheroids of HeLa cells loaded with TAMRA-labeled NRs. a) Three 
different views of a 3D reconstruction of a NR-loaded spheroid with diameter ~ 1 µm. b) Different stacks of the 
spheroid shown in a. Scale bars correspond to 100 µm 
  
 
Figure S30. 3D reconstructions of spheroids of NR-preloaded HeLa cells treated with the substrate 5. a) First 
generation of 6 after 24 h incubation of 5 (20 µM). b) 24 h cleansing. c) Second generation of 6 after 24 h 
incubation of 5 (20 µM). d) Control experiment of “empty” (Pd “free”) spheroids incubated during 24 h with 
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